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Summary
The human adapter protein Nck is an important modulator of the actin cytoskele-
ton. It also is crucial to the infection strategy of enteropathogenic E.coli (EPEC). On
contact with human intestinal cells, the EPEC type III secretion system translocates
the virulence factor Tir (translocated intimin receptor) into the host cytoplasm which
is subsequently inserted into the host cell membrane. Upon tyrosine phosphorylation,
the cytoplasmic, C-terminal domain of Tir becomes a high-affinity ligand to the SH2
domain of Nck. Recruitment of Nck results in local remodeling of the host cell cytoskele-
ton leading to the formation of actin-rich pedestals on which the bacteria reside. Two
isoproteins of Nck, Nck1 and Nck2, exist in vertebrates, both of which are recruited by
phosphorylated Tir. The precise cellular functions of Nck1 and Nck2 presently remain
unclear, though both have been reported to bind a number of human proteins through
their SH2 and SH3 domains. Differences between Nck1 and Nck2 likewise remain elu-
sive as several interaction partners are known to bind both proteins whereas others
have been reported to interact exclusively with a single Nck family member.
The binding properties of Nck1 and Nck2 SH2 domains were investigated both bio-
physically and structurally to resolve their ligand recognition specificity. Of all binding
partners examined, both Nck1 and Nck2 bind a Tir-derived tyrosine phosphorylated
peptide with highest affinity. Crystal structures of the Nck1 and Nck2 SH2 domains in
complex with this Tir-derived phosphopeptide as well as the uncomplexed Nck1 SH2
domain reveal a common structure and indicate that ligand-binding involves regions
conserved between Nck1 and Nck2. An epitope scan, based on the Tir phosphopeptide,
identified the binding specificity of Nck1 and Nck2 confirming that the Tir peptide
sequence is essentially optimal for high affinity peptide binding to both proteins. A
search of human protein databases using the refined peptide sequence identified po-
tentially new interaction partners for Nck SH2 domains, among them the G-protein
coupled receptor kinase interacting protein GIT1. Pull-down assays with both Nck SH2
domains indicate that this predicted interaction may be relevant also in vivo.
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Chapter 1
Introduction
Signal transduction processes are vital for the cell to respond to changing environmental
conditions. Pathogenic microorganisms have evolved diverse strategies to exploit cel-
lular functions of eukaryotic organisms by reprogramming signalling pathways to their
own advantage. Frequently, they make use of the host actin cytoskeleton to facilitate
their own spread, by subverting the regulatory systems controlling actin polymeriza-
tion in the host cell. Investigating the intricate mechanisms of manipulation developed
by pathogens not only allows us to comprehend infection processes but also provides a
fundamental appreciation of the molecular machinery of our own cells.
1.1 Regulation of the actin cytoskeleton
The outer morphology and internal organization of eukaryotic cells is vitally depen-
dent on the integrity of the actin cytoskeleton. Temporally and spatially coordinated
actin filament formation and dissolution is essential for processes such as forming of
membrane protrusions during cell locomotion, vesicle trafficking and, unintended by
the cell, the intracellular motility of several opportunistic pathogens. Actin polymer-
ization responds to external stimuli and is regulated through a complex array of signal
transduction pathways.
Actin is the most abundant protein in eukaryotic cells (for review see Pantaloni et al.
(2001)). The 43-kDa protein binds ATP and dynamically shuttles between two distinct
physical states: monomeric, globular (G)-actin and filamentous (F)-actin. Polymeriza-
tion of (G)-actin occurs spontaneously, when its concentration rises above a critical
threshold (in vitro 0.1 µM, Korn et al. (1987)). Polymerization is believed to be ini-
tiated by the entropically unfavourable formation of a trimeric actin polymerization
nucleus. Thereafter, the filament extends rapidly through the addition of further (G)-
actin molecules. Conformational changes in actin induced by polymerization stimulate
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hydrolysis of actin bound ATP to ADP and inorganic phosphate (Korn et al., 1987).
Actin polymerization is 5-10 times faster at the (+) end where ATP bound (G)-actin
is incorporated, than at the (–) end due to a conformational change in the individual
actin molecule upon hydrolysis of ATP. This provides the basis for a dynamic process
known as treadmilling that is driven by ATP hydrolysis: the (+) end grows at the same
rate as the (–) end depolymerizes, maintaining a roughly constant length of the fila-
ment (Fig. 1.1). Treadmilling provides the mechanical energy for locomotion processes
and allows the dynamic regulation of actin polymerization in the cell, taking a crucial
role in cell motility.
Figure 1.1: Treadmilling. The dynamic process of actin filament formation (adapted from
Pantaloni et al. (2001)). ATP-binding (G)-actin monomers (blue) are added to the (+) end.
Filament formation promotes ATP hydrolysis and thereby facilitates depolymerization at the
(–) end (yellow).
In the cell, a plethora of actin binding proteins controls the tight regulation of actin
filament formation and disassembly. Several (G)-actin binding proteins serve to pre-
vent spontaneous actin polymerization. De novo actin nucleation therefore is strictly
reserved to “nucleation complexes”, the best characterized being the Arp2/3 complex
(Arp – actin-related protein, for review see Higgs & Pollard (2001)). It consists of the
actin-related proteins Arp2 and Arp3, and five other proteins p16, p20, p21, p34 and
p40. Together Arp2 and Arp3 are assumed to mimick the (–) end of an actin fila-
ment, inducing actin polymerization once a (G)-actin monomer has completed the
trimeric nucleus (Kelleher et al., 1995). Without further activating factors, the Arp2/3
complex, however, only shows little actin nucleating activity in in vitro experiments
(Mullins et al., 1998; Welch et al., 1998). So-called “nucleation promoting factors” are
needed to activate the complex, among them the proteins of the WASP/Scar family,
N-WASP (neuronal Wiskott-Aldrich syndrome protein) being the most potent acti-
vator (for review see Stradal et al. (2004)). The WASP/Scar family proteins exhibit
multiple domains that bind to numerous proteins involved in signal transduction reg-
ulating actin polymerization in response to various signals. The proteins share several
characteristics including the VCA (verprolin homology, cofilin homology or central, and
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acidic) domain. This domain binds monomeric (G)-actin as well as the Arp2/3 complex,
thereby activating its actin nucleation ability (Panchal et al., 2003). N-WASP, however,
auto-inhibits itself requiring signalling proteins for activation. For example, binding of
Cdc42 (a Rho-GTPase) conformationally changes N-WASP into an Arp2/3 activating
form (Miki et al., 1998). Several other molecules can similarly activate N-WASP, often
working in concert (Fig. 1.2).
Figure 1.2: N-WASP integrates several signalling pathways for actin remodelling
via the Arp2/3 complex. PIP2 – phosphatidylinositol-4,5-bisphosphate; SH3 – Src homol-
ogy 3 domain containing proteins.
1.1.1 N-WASP activation by Nck, an SH2/SH3 adapter pro-
tein
N-WASP in vitro activation has also been demonstrated for Src homology 3 (SH3)
domain containing proteins, among them several activators that exclusively exhibit
SH2 and SH3 domains (Rivero-Lezcano et al., 1995; Miki et al., 1996; She et al., 1997;
Carlier et al., 2000; Rohatgi et al., 2001). These proteins lack enzymatic activity and
therefore are regarded as adapter proteins that link tyrosine phophorylated proteins
through their SH2 domains to proline-rich molecules binding their SH3 domains. One
such adapter molecule regulating actin dynamics through N-WASP is Nck (Fig. 1.3,
Rivero-Lezcano et al. (1995)). The SH3 domains of Nck interact with the proline-rich
region of N-WASP while the SH2 domain is able to detect the phosphorylation of
receptor tyrosine kinases or cytoplasmic proteins in response to external stimulation
(e.g. growth factors). Nck has been reported to partially activate N-WASP on its own
(Fukuoka et al., 2001) and fully activate it in synergy with PIP2 (phosphatidylinositol-
4,5-bisphosphate) (Rohatgi et al., 2001).
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Figure 1.3: Domain organization of the SH2/SH3 adapter protein Nck. SH2 – Src
homology 2 domain; SH3 – Src homology 3 domain.
1.2 The role of Nck in actin cytoskeleton manipu-
lation by pathogens
1.2.1 The virulence factor A36R from vaccinia
The spreading mechanism of vaccinia virus is an excellent example for actin filament
recruitment through phosphotyrosine signalling involving Nck. Vaccinia virus is the
prototype of the poxvirus family (for review see Smith et al. (2003)) and its use as a
vaccine against smallpox has essentially eradicated this disease from the world. Vac-
cinia is the only virus known so far to manipulate the host actin cytoskeleton. Following
replication, vaccinia recruits actin filaments that push the virus towards the neighbour-
ing cells allowing it to spread (Fig. 1.4).
Figure 1.4: Vaccinia virus recruiting actin from its host cell. Green – actin stained
with phalloidin; red – the actin-binding protein cortactin (antibody stained); yellow – cortactin
is associated with actin indicating dynamic sites of actin remodelling; arrowheads – the viruses
(not visible) are located at the tip of the actin tail; (modified according to Frischknecht &
Way (2001)).
CHAPTER 1. INTRODUCTION 14
After replication, the virus is surrounded by two membranes. The outer membrane ex-
poses the 25 kDa protein A36R (Parkinson & Smith, 1994). To spread and infect other
cells, the virus attaches to the host motor protein kinesin and travels on microtubules
to the cell periphery (Rietdorf et al., 2001). Its outer membrane fuses with the plasma
membrane, the virus however remains attached to the cell. The viral transmembrane
protein A36R that is now incorporated in the host cell membrane is phosphorylated
at Tyr112 and Tyr132 (Frischknecht et al., 1999; Scaplehorn et al., 2002), and thereby
recruits Nck (Y1121) and Grb2 (Y132), another SH2/SH3 adapter protein, through
their SH2 domains. In contrast to Grb2, Nck binds to WIP (WASP/Scar interacting
protein), another N-WASP interacting protein (Frischknecht et al., 1999; Scaplehorn
et al., 2002) through its SH3 domains. Nck, Grb2 and WIP finally recruit N-WASP, and
thereby activate the Arp2/3 complex for actin polymerization (Fig. 1.5, Frischknecht
et al. (1999); Moreau et al. (2000); Scaplehorn et al. (2002)). As a consequence, the
virus is lifted up on fingerlike protrusions from the host membrane, facilitating its
cell-to-cell spread.
Figure 1.5: The virulence factor A36R from vaccinia manipulates the host actin
polymerization via recruiting the adapter protein Nck. Y112P – phosphorylated
Tyr112; Y132P – phosphorylated Tyr132.
1.2.2 The virulence factor Tir of enteropathogenic Escheri-
chia coli
Enteropathogenic E. coli (EPEC), a Gram-negative pathogenic bacterium, exploits Nck
in a mechanism remarkably reminiscent of vaccinia. EPEC is an extracellular human
pathogen that causes severe diarrhea. It induces histopathological alterations of the
1Note that interaction sites necessarily have to be phosphorylated to bind SH2 domains. Phospho-
rylation, hence, is implied even if not mentioned explicitly.
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intestinal enterocytes that result in microvillar effacement and formation of (F)-actin
filled pedestals beneath the site of bacterial attachment (Fig. 1.6, for review see Nataro
& Kaper (1998)).
Figure 1.6: Enteropathogenic E. coli (red) induce the formation of pedestals
(brown) on intestinal enterocytes. Scanning electron microscopy, modified according
to Manfred Rohde, GBF, Germany.
As a first step in pedestal formation, the bacterium adheres tightly to the host mem-
brane and abolishes the natural microvilli structure, a process known as attaching-
and-effacing mechanism (Moon et al., 1983). For this purpose, it transports several
virulence factors into the host cell using its type III secretion system. One such factor
is the translocated intimin receptor (Tir), that is subsequently inserted into the host
cell membrane (Kenny et al., 1997). The extracellular part of Tir is recognized by the
EPEC outer membrane protein intimin allowing the bacterium to closely attach to the
host cell membrane. In the intracellular, C-terminal domain of Tir, the residue Tyr474
is phosphorylated by a host kinase in response to clustering of Tir through intimin
(Campellone et al., 2004; Phillips et al., 2004). Phosphorylated Tir is now specifically
recognised by the SH2 domain of the human adapter protein Nck (Gruenheid et al.,
2001). The three SH3 domains of Nck serve to further recruit proteins such as N-WASP
and hence induce localized Arp2/3 complex activation (Kalman et al., 1999; Gruenheid
et al., 2001; Campellone et al., 2004). Directed actin polymerization at the site of bac-
terial attachment causes the host cell membrane to protrude by up to 10 µm beyond
the remaining membrane creating the dynamic pedestal (Rosenshine et al. (1996), Fig.
1.7).
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Figure 1.7: Simplified molecular mechanism of pedestal formation. Y474P –
phosphorylated Tyr474. In vivo, N-WASP is not directly recruited via Nck, the detailed
mechanism though is not yet fully understood.
1.3 The Nck family in its cellular context
Compared to its well-characterized role in EPEC and vaccinia infections, the phys-
iological function of Nck is currently not as clear – though a role in actin filament
organization is evident. Nck proteins are implicated via their SH2 domains in tyrosine
kinase based signal transduction pathways and are frequently linked to alterations of
the actin cytoskeleton through downstream targets recruited by their SH3 domains.
Nck is an adapter protein family that consists of two isoproteins: Nck1 (Nckα) and
Nck2 (Nckβ) in humans (for review see Buday et al. (2002)). Both family members
have also been found in mice (mNck1; mNck2/Grb4). Drosophila melanogaster (Dock,
Garrity et al. (1996)), Xenopus laevis (Tanaka et al., 1997) and Caenorhabditis elegans
(Chen et al., 1998) by contrast only have a single nck gene. All Nck proteins share
the same domain architecture composed of three SH3 domains followed by an SH2
domain. The two human gene products exhibit a molecular mass of 43 kDa from which
more than 79% of all amino acids belong to the SH domains (Chen et al., 1998). The
sequence identity between Nck1 and Nck2 is 68% rising to 82% for the SH2 domains.
1.3.1 Interaction partners of Nck
Apart from the virulence factors A36R and Tir, various cellular interaction partners
for both SH2 and SH3 domains of Nck have been found to date. Over 20 interaction
partners of the Nck SH3 domains have been identified. Most of these regulate the
actin cytoskeleton directly or indirectly (Li & She, 2000) presumably by recruiting
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proline-rich proteins to the membrane (Pramatarova et al., 2003) or to multiprotein
complexes associated with the actin cytoskeleton. Upstream, Nck transmits external
stimuli from growth factors by binding to tyrosine phosphorylated proteins through
its SH2 domain (Tab. 1.1). Binding partners include receptor tyrosine kinases such as
epithelial growth factor (EGF) and platelet derived growth factor (PDGF) receptor
(Chou et al., 1992; Li et al., 1992; Meisenhelder & Hunter, 1992; Park & Rhee, 1992),
as well as tyrosine phosphorylated docking proteins like p62Dok, a 62-kDa RasGAP-
associated phosphotyrosine protein (Holland et al., 1997; Noguchi et al., 1999; Becker
et al., 2000).
Table 1.1: Binding partners of Nck SH2 domains according to the literature.
Extended after Buday et al. (2002). “tbd” – to be determined. Note that “tbd” in third row
means that experiments either did not distinguish between Nck1 and Nck2 or were performed
before the discovery of Nck2 (cross reactions with Nck2 in experiments can thus not be
excluded).
Phosphoproteins Binding sites Interaction References
partner
A36R (vaccinia) Y112 tbd (Frischknecht et al., 1999)
Bcr-Abl tbd Nck2 (Coutinho et al., 2000)
Disabled-1 (Dab-1) Y220 Nck2 (Pramatarova et al., 2003)
Y232 Nck2 (Pramatarova et al., 2003)
Dok1 Y361 tbd (Holland et al., 1997)
(Tanaka et al., 1997)
(Murakami et al., 1999)
(Noguchi et al., 1999)
(Becker et al., 2000)
Dok2 (Dok-R) Y351 tbd (Jones & Dumont, 1999)
(Jones & Dumont, 1998)
(Lock et al., 1999)
EGF receptor tbd tbd (Li et al., 1992)
(Park & Rhee, 1992)
EphB1 Y594 tbd (Stein et al., 1998)
ephrinB1 Y298 Nck2 (Cowan & Henkemeyer, 2001)
(Bong et al., 2004)
ephrinB2 Y304 Nck2 (Su et al., 2004)
Flt-1 (VEGFR-1) Y1213, Y1333 tbd (Ito et al., 1998)
(Igarashi et al., 1998)
Flk-1 (VEGFR-2) tbd tbd (Kroll & Waltenberger, 1997)
IRS-3 tbd tbd (Xu et al., 1999)
PDGF receptor Y751 Nck1 (Nishimura et al., 1993)
Y1009 Nck2 (Chen et al., 2000)
met/HGF receptor tbd tbd (Kochhar & Iyer, 1996)
RET tbd tbd (Bocciardi et al., 1997)
SLP-76 Y113, Y128 tbd (Bubeck Wardenburg et al., 1998)
(Wunderlich et al., 1999)
Tir (EPEC) Y474 Nck1, Nck2 (Gruenheid et al., 2001)
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Although a variety of phosphoprotein targets for Nck has been described, the physio-
logical relevance of these protein-protein interactions is still poorly understood (Buday
et al., 2002). Most likely, not every target found to date will be confirmed to play an
important role in Nck signalling.
1.3.2 Functional differences between Nck1 and Nck2
Nck2 was identified in 1998 by Tu et al., eight years after the description of the Nck1
cDNA (Lehmann et al., 1990). In 1994, the nck1 gene was tracked to the 3q21 locus
of chromosome 3 (Huebner et al., 1994). Nck2 by contrast occupies the 2q12 locus on
chromosome 2 (Chen et al., 1998). Nck1 is broadly expressed during embryonal devel-
opment of the mouse, but expression of nck2 is restricted to the developing nervous
system, endoderm and mesodermal derivatives in later stages of embryonal develop-
ment (Bladt et al., 2003). Both nck genes are expressed in a wide variety of adult
tissues (Chen et al., 1998; Bladt et al., 2003). Nck1 appears to be produced ubiqui-
tously in comparable amounts, Nck2 has not been found in liver and less abundant in
brain. An Nck1-/-, Nck2-/- double knock-out is lethal in mice but single gene deletions
(Nck1-/- or Nck2-/-) show undistinguishable phenotypes when compared to wildtype
mice (Bladt et al., 2003). This observation would indicate that either Nck can substan-
tially substitute for the other – thus preventing a detectable phenotype.
This compensatory effect is less clear regarding cell biological experiments. In some
cases Nck1 and Nck2 have been shown to share the same interaction partners while
other partners have been reported to interact exclusively with either Nck1 or Nck2.
Several poly-proline proteins, that recruit SH3 domains, have been found to bind to
both proteins. These include PAK1, Abi-1 and dynamin (Cowan & Henkemeyer, 2001),
all implicated in cytoskeletal dynamics. The adapter protein PINCH, a protein involved
in integrin signalling, is the first SH3 domain interaction partner, found to bind only
Nck2, interacting with the fourth LIM domain of PINCH through its third SH3 domain
(Tu et al., 1998). Nck1, in contrast, does not appear to bind this LIM domain.
As far as the SH2 domain is concerned, both Nck1 and Nck2 are able to mediate
pedestal formation in EPEC infection by recognizing Tir as described above (Gruen-
heid et al., 2001). However, whereas Nck2 has been shown to interact with three proteins
involved in neuronal signalling, Disabled-1 (Dab-1), ephrinB1 and ephrinB2 in a phos-
photyrosine dependent manner, a comparable interaction for Nck1 could not be shown
(Cowan & Henkemeyer, 2001; Pramatarova et al., 2003; Bong et al., 2004; Su et al.,
2004). Dab-1 is a tyrosine phosphorylated protein, essential for signal transmission
upon receptor binding of the glycoprotein Reelin that regulates neuronal placement
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during brain development. EphrinB1 and ephrinB2 are involved in cell-cell recogni-
tion of neuronal cells e.g. in axon guidance and hindbrain segmentation (Cowan &
Henkemeyer, 2001) and exhibit the same peptide sequence around Tyr298 and Tyr304,
respectively. Similarly, Nck1 was shown to preferentially bind phosphorylated Tyr751
of the PDGF receptor whereas Nck2 prefers Tyr1009 (Chen et al., 2000). The reason
of these observations is currently not clear. The discovery of different tyrosine phos-
phorylated binding partners for Nck1 and Nck2 suggests significant differences in SH2
recognition motifs (Cowan & Henkemeyer, 2001).
1.4 SH2 domains as key regulators in phosphotyro-
sine signal transduction
Tyrosine phosphorylation is an essential element in signal transduction during cell
growth, differentiation and oncogenesis. The discovery of Src homology 2 (SH2) do-
mains by Koch et al. (1991) as recognition modules for tyrosine phosphorylated pro-
teins has been a breakthrough in understanding signal transduction (for review see
Bradshaw & Waksman (2002)). The ability of SH2 domains to discriminate phospho-
rylated from unphosphorylated tyrosines provides a molecular mechanism of recruiting
enzymatic activity in response to external signals. SH2 domains are, however, not ex-
clusive to enzymes such as kinases and phosphatases. Instead they are also common
to adapter proteins such as Nck or Grb2 that lack any enzymatic activity but in turn
help to subsequently recruit enzymes.
SH2 domains are modules of ∼ 100 amino acids that have been identified in more than
100 human proteins (Bradshaw & Waksman, 2002). A sequence alignment of Nck1 and
Nck2 SH2 domains with the SH2 domains of Src (the tyrosine kinase from which the
SH domains were described first), Grb2 and Lck (a Src-like kinase) is shown in Fig.
1.8. The annotation of residues has been first defined by Eck et al. (1993) based on the
secondary structure of Lck and is shown below the sequence alignment.This annotation
is used throughout the study for assignment of amino acid residues and SH2 domain
comparisons.
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Figure 1.8: Sequence alignment of SH2 domains. Numbers above amino acids corre-
spond to the sequence position in Nck1. A general annotation for SH2 residues was introduced
by Eck et al. (1993), and is based on the secondary structure of Lck. The annotation used
here is slightly modified and shown below the alignment. Secondary structure elements are
assigned using α for α-helices or β for β-strands and consecutively numbered alphabetically,
e.g. αA for the first α-helix in the molecule. Loops are named using the letters of the preced-
ing and the following secondary structure element, e.g. loopBC for the loop region between
β-strands B and C. Residues are named using the annotation of the secondary structure
element followed by their position, e.g. ArgβB5 for the arginine 308 in Nck1 that is located
at the fifth position in the β-strand βB. Likewise, residues in loop regions are labelled ac-
cording to the encompassing secondary structure, e.g. GluAB1 for the first residue following
the αA helix. Missing residues in Nck are dismissed meaning that AlaβC8 (Ala323 in Nck1)
is followed by GlnCD4 (Gln324 in Nck1).
The interaction of an SH2 domain with its target can be simulated by substituting
the target by a synthetic phosphotyrosine peptide corresponding to the amino acid se-
quence adjacent to the phosphorylated tyrosine (Mayer et al., 1991, 1992). The binding
constants of SH2 domains for interaction partner derived phosphopeptides normally lie
in the range of 100 nM to 1 µM (Ladbury et al., 1995). The phosphotyrosine is crucial
to this recognition as unphosphorylated peptides of the same sequence reduce affinity
by at least three orders of magnitude (Bradshaw et al., 1999). The same is true, if
the phosphotyrosine is replaced by phosphoserine or phosphothreonine. The flanking
residues, nevertheless, are still essential for high-affinity binding.
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Figure 1.9: SH2 domain of the tyrosine kinase Src. Left: ribbon diagram of the SH2
domain in complex with the high-affinity peptide Y-E-E-I included as stick model labelled
according to Eck et al. (1993). Right: Surface representation of the SH2 domain. Colours
indicate the electrostatic potential: blue – positively charged, red – negatively charged, white –
neutral. The phosphotyrosine binding pocket (blue) and the hydrophobic pocket enclosing
the residue at position +3 (white) are encircled (modified from Waksman et al. (1993); Yaffe
(2002)).
Various complexes of SH2 domains binding phosphotyrosine peptides have been de-
scribed by X-ray crystallography and nuclear magnetic resonance (for details see Brad-
shaw & Waksman (2002)). The overall fold of SH2 domains comprises a central anti-
parallel β-sheet flanked by two α-helices (see SH2 domain of Src kinase as example
in Fig. 1.9). A highly conserved phosphotyrosine binding pocket is located in the
N-terminal half between the central β-sheet and the first α-helix. The phosphate is
bound through an intricate network of hydrophobic and electrostatic interactions. Two
arginines (ArgαA2 and ArgβB5) are crucial for recognition and are conserved in most
SH2 domains. Residues contributing to specificity in the peptide predominantly are
located C-terminally to the phosphotyrosine. Similarly most residues involved in re-
cognizing the peptide are located in the C-terminal half of the SH2 domain between
the central β-sheet and the second α-helix. The binding specificity of various SH2 do-
mains, inter alia Nck1, were determined using a phosphopeptide library allowing for
a classification of SH2 domains (Songyang et al., 1993). In this regard, residue βD5 is
particularly instrumental for binding specificity and therefore a central constituent of
the classification.
Most SH2 domains, including that of Nck1, are grouped as “Src like”.They are char-
acterized by a tyrosine or a phenylalanine at position βD5 and preferentially bind a
peptide exhibiting the sequence pY-hydrophilic-hydrophilic-I/P (“p” indicates the ne-
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cessary tyrosine phosphorylation). The Src family of kinases constitutes a subgroup
that prefers pY-E-E-I.
Another group of SH2 domains bears an isoleucine or cysteine at position βD5. The
preferred phosphopeptide sequence here is pY-hydrophobic-X-hydrophobic. For exam-
ple, both SH2 domains of p85 subunit of PI 3-kinase, belonging to this SH2 group,
share a strong preference for methionine at position +3.
The SH2 domains, described above, all bind extended phosphopeptides. A subgroup
that includes Grb2, should belong to the Src like SH2 domains due to conservation
of the βD5 residue. However, it does not select specifically for positions +1 and +3
as Src like SH2 domains do, but favours an asparagine at position +2. The resulting
consensus sequence is pY-X-N-X. Structurally, a bulky tryptophane is seen to fill the
+3 pocket causing the peptide to fold back in a hairpin. The specificity to the +3
position is lost while asparagine at position +2 now creates the defining interactions
with the SH2 domain.
1.4.1 Binding specificities of Nck SH2 domains
The preferred binding sequence for the Nck1 SH2 domain was first identified as pY-D-
E-P/D/V (Songyang et al., 1993) placing it into the Src-like group of SH2 domains.
Protein sequences of interaction partners, however, indicate that this sequence is too
restrictive. The pathogenicity factors A36R and Tir agree quite well with the pattern
pY-D-E-P/D/V with their sequences pY-D-S-V and pY-D-E-V. In Flt-1 vascular en-
dothelial growth factor receptor-1, on binding sequence was determined to pY-S-T-P
(Y1333) retaining some similarity to pY-D-E-P/D/V whereas the second binding site
pY-V-N-A (Y1213) differs significantly (Igarashi et al., 1998; Ito et al., 1998). Y751 on
the PDGF-receptor is also known as binding site for Nck1 but its sequence pY-V-P-M
differs significantly from the proposed binding motif (Nishimura et al., 1993). Simi-
larly, Y147 of IRS-1 does not correspond to the preferred sequence with pY-D-T-G
(Lee et al., 1993).
In the classical experiment of Songyang et al. (1993), the binding specificity of Nck1
only was tested while nothing is known about the interaction preferences of Nck2. The
identification of Dab-1 as specific interaction partner for Nck2 suggested recognition
of a pY-X-V-P motif, as the binding sites were determined to be pY-Q-V-P (Y220)
and pY-D-V-P (Y232) (Pramatarova et al., 2003). However, this motif was not sup-
ported further as ephrinB1 (Y298) and ephrinB2 (Y304) were shown to specifically
recruit Nck2 through binding sites containing both the sequence pY-E-K-V (Cowan &
Henkemeyer, 2001; Bong et al., 2004; Su et al., 2004).
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Determining the phosphotyrosine binding specificities of Nck1 and Nck2 would aid
significantly the identification of interaction partners and thus of the physiological
functions of Nck1 and Nck2 in actin cytoskeleton signalling.
1.5 Aim of the work
The SH2 domains of Nck1 and Nck2 were to be investigated biophysically and struc-
turally with the particular emphasis on characterizing and quantifying their ligand
binding specificities.
Dissociation constants for Nck interaction partner-derived phosphopeptides were to be
determined for both SH2 domains. In particular reported differences in binding speci-
ficities were to be validated. The three-dimensional structure of both SH2 domains were
to be solved in complex with a physiologically binding partner – ideally either of the
virulence factors Tir or A36R, alternatively with relevant phosphopeptides containing
the essential binding site. An epitope scan was to identify the optimal binding residue
for each position of a phosphopeptide, mapping the interaction specificities for Nck1
and Nck2 SH2 domains in detail.
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Chapter 2
Materials and Methods
2.1 Chemicals, buffers and media
2.1.1 Chemicals
If not stated otherwise, all chemicals were purchased from the following companies:
Aldrich, Amersham Biosciences, Difco, Emerald Biostructures, Fluka, Gerbu, GIBCO
BRL, Hampton Research, Merck, Millipore, Qiagen, Riedel de Haen, Roche, Roth,
Sigma, and Stratagene. The quality standard was “pro analysis” (p.a.).
2.1.2 Buffers
Buffers used in several methods are described below, further solutions will be listed in
the corresponding method description.
PBS (pH 7.5)
NaCl 0.14 M
KCl 3 mM
Na2HPO4 1 mM
KH2PO4 2 mM
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2.1.3 Media
LB-medium tryptone 10 g/L
(“Luria Bertani broth”) NaCl 10 g/L
yeast extract 5 g/L
LB-Amp-medium LB-medium
ampicillin 100 µg/mL
LB-Amp-Cm-medium LB-medium
ampicillin 100 µg/mL
chloramphenicol 34 µg/mL
LB-Kan-medium LB-medium
kanamycin 34 µg/mL
LB-Kan-Cm-medium LB-medium
kanamycin 34 µg/mL
chloramphenicol 34 µg/mL
LB-Amp-Cm-agar LB-medium
Bacto-agar 16 g/L
ampicillin 100 µg/mL
chloramphenicol 34 µg/mL
SOB-medium tryptone 20 g/L
yeast extract 5 g/L
NaCl 10 mM
KCl 2.5 mM
SOC-medium SOB-medium
MgCl2 10 mM
MgSO4 10 mM
Glucose 2 mM
All media were sterilized by autoclaving (30 min, 121 ). Heat-sensitive compo-
nents (e.g. antibiotics) were sterilized by filtration and separately added to the sterile
medium.
2.2 Bacterial strains
Cultivation of bacteria was carried out at 37 overnight in LB-medium or on LB-
agar plates containing suitable antibiotics. For long term storage, cells in LB-medium
containing 10% glycerole were maintained at -20.
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Table 2.1: E. coli strains.
E. coli strain Genotype Company
BL21 CodonPlus
(DE3)-RIL
F− ompT hsdS(rB−mB−) dcm+ Tetr galλ
(DE3) endA Hte [argU ileY leuW Camr]
Stratagene
XL1-Blue super-
competent cells
recA1 endA1 gyrA96 thi−1 hsdR17 supE44
relA1 lac [F’ proAB laclqZ∆M15 Tn10
(Tetr)]
Stratagene
Rosetta F− ompT hsdSB(r−Bm
−
B)gal dcm pRARE2
pAR5615 (AmpR, CamR)
Novagen
BL21 Star pLysS F− ompT hsdS(rB−mB−) gal dcm rne131
(DE3) pLysS Camr
Stratagene
TG2 supE hsd∆5 thi∆ (lac − proAB) ∆
(srl − recA) 306 :: Tn10) (tetr) F’
[traD36proAB+lacIqlacZ∆M15]
Stratagene
2.3 Antibodies
Primary antibodies
Name Antibody Antigen Conjugate Company
species
anti GST HRP conjugate mouse GST horse-radish Amersham
peroxidase Biosciences
anti penta-His mouse penta-His — Qiagen
Secondary antibodies
Name AB- AB- A/R- A/R- Company
conjugate species species name
A4a peroxidase goat mouse IgG + IgM (H+L) Dianova
2.4 Molecular weight standards
Name Company Type Usage
1 kb Plus DNA Ladder GibcoBRL DNA marker Agarose gel electroph.
10 kDa Protein Ladder GibcoBRL Protein marker SDS gel electroph.
Prestained, Broad Range BioRad Protein marker Western blot
Benchmarker Invitrogen Protein marker SDS gel electroph.
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2.5 Molecular biology
2.5.1 Polymerase chain reaction
The polymerase chain reaction (PCR) was used to amplify DNA. Suitable oligonu-
cleotides for the sequence of interest were designed and then purchased from Gibco-
BRL. Amplification was achieved by repeated cycles of denaturing the template DNA,
cooling to anneal the primers, and increasing the temperature again to an optimal
temperature for the polymerase to copy the sequence of interest. The typical proto-
col is shown below. The temperature gradient was chosen depending on the melting
temperature of the primers.
PCR-mix
DNA-template (∼ 50 ng) 1.0 µL
5’-Primer (25 pmol/µL) 0.25 µL
3’-Primer (25 pmol/µL) 0.25 µL
dNTPs (2.5 mM/nucleotide) 4.0 µL
10Ö PCR-buffer 5.0 µL
Pwo polymerase (5U/µL) 0.5 µL
sterile water 39.0 µL
Program
1 cycle 95 300 s
72 420 s
34 cycles 94 60 s
gradient 60 s
68 60 s
1 cycle 68 180 s
4 constant
CHAPTER 2. MATERIALS AND METHODS 28
Table 2.2: Primers used for PCR. Restriction sites are underlined.
Oligonucleotide Sequence Restriction site
TIR-PGEX-3’ 5’-GGCGCTCGAGTTAAACGAAACGTACT-
GGTCC
XhoI
TIR-5’-C-TERM 5’-GGTCGGATCCCGAAATCAGCCGGCAG-
AAC
BamHI
TIR-PQE-3’ 5’-CGCGGGATCCAACGAAACGTACTGGT-
CCC
BamHI
NCK1-SH2-5’ 5’-GGTCGGATCCCCTTGGTATTATGGCA-
AAGTCAC
BamHI
NCK1-PGEX-3’ 5’-GGCGCTCGAGTCATGATAAATGCTTG-
ACAAGATA
XhoI
NCK1-PQE-3’ 5’-CGCGGGATCCTGATAAATGCTTGACA-
AGATATAAT
BamHI
NCK2-SH2-5’ 5’-GGTCGGATCCGAGTGGTACTACGGGA-
ACGTG
BamHI
NCK2-PGEX-3’ 5’-GGCGCTCGAGTCACTGCAGGGCCCT-
GACGAG
XhoI
NCK2-PQE-3’ 5’-CGCGGGATCCCTGCAGGGCCCTGAC-
GAGG
BamHI
A36RCYTO-BAMHI-5’ 5’-CGCGGATCCAGGAAAAAGATACGTAC-
TGTCTATAATG
BamHI
A36RCYTO-NCOI-5’ 5’-CATGCCATGGGAAGGAAAAAGATACG-
TACTGTCTATAATG
NcoI
A36RCYTO-BAMHI-3’ 5’-CGCGGATCCCACCAATGATACGACCG-
ATGATTC
BamHI
A36RCYTO-NOTI-3’ 5’-ATAAGAATGCGGCCGCTCACACCAAT-
GATACGACCGATGATTC
NotI
A36RCYTO-BGLII-3’ 5’-GAAGATCTCACCAATGATACGACCGA-
TGATTC
BglII
NCK2-SH2-NOTI-3’ 5’-ATAAGAATGCGGCCGCTCACTGCAGG-
GCCCTGACGAG
NotI
NCK1-SH2-NCOI-5’ 5’-CATGCCATGGGACCTTGGTATTATGG-
CAAAGTCAC
NcoI
NCK1-SH2-NOTI-3’ 5’-ATAAGAATGCGGCCGCTCATGATAAA-
TGCTTGACAAGATA
NotI
NCK2-SH2-NCOI-5’ 5’-CATGCCATGGAGTGGTACTACGGGAA-
CGTG
NcoI
For cloning of PCR fragments into vectors, the fragments were cleaved with 5 U of the
appropriate restriction endonucleases directly in the PCR mix for 1-4 h. The DNA was
purified using the QIAquick gel extraction kit (Qiagen).
2.5.2 Isolation of plasmids from E. coli
Isolation of plasmids was performed using QIAprep® Miniprep (Maxiprep) Kits from
Qiagen. For high-copy plasmids, 5 mL (100 mL) of an overnight culture were cen-
trifuged for 1 min (15 min) at 20’800Ög (6’000Ög). The supernatant was discarded.
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The following steps were performed according to the manual (protocol “using a micro-
centrifuge”). Purified plasmids were eluted with 50 µL (200 µL) of water and stored at
-20 .
2.5.3 Restriction enzyme mediated plasmid digestion
0.5 µg plasmid were mixed with 1.5 µL 10Ö enzyme buffer, 20 U restriction endonu-
clease and 10 µL water were incubated for 1-2 h at 37. Digested plasmids were
analyzed by agarose gel electrophoresis and purified using the QIAquick gel extraction
kit (Qiagen).
2.5.4 Dephosphorylation of vectors
To lower the rate of religated empty vectors, all vectors were dephosphorylated prior to
ligation. 1 U Shrimp-alkaline phosphatase per µL vector was incubated in appropriately
buffered vector solution for 15 min at 37 °C to perform the dephosphorylation. Another
15 min of heating to 65 °C inactivated the Shrimp-alkaline phosphatase.
2.5.5 Ligation
For the ligation of PCR fragments with vectors, the appropriately cleaved insert and
vector were analyzed using agarose gel electrophoresis to estimate the amount of DNA.
The ligation mix was incubated with 4Ö excess of insert overnight at 4.
Ligation mix
dephosphorylated vector 4 µL
cleaved insert 1 µL
10Ö ligation buffer 2 µL
T4 DNA ligase (1U/µL) 1 µL
sterile water 12 µL
2.5.6 Transformation of CaCl2-competent E. coli cells
Transformations were performed under sterile conditions. 50 µL of CaCl2-competent
E. coli bacteria were thawed on ice, transferred to a 1.5 mL reaction tube, and gently
mixed with approximately 0.2 µg plasmid. The mixture was incubated for 30 min on
ice, then heat-shocked for 90 s at 42, and cooled again on ice for 2 min. After addition
of 0.5 mL SOC-Medium, the cells were shaken for 1 h at 37. Centrifugation for 1
min at 20’800Ög pelleted the cells before resuspendeding again in 100 µL medium
and plating onto LB-agar plates containing suitable antibiotics. Colonies were grown
overnight at 37.
2.5.7 Agarose gel electrophoresis
25 mL of 1% agarose in TAE-buffer were heated until liquidation, cooled to approx-
imately 40 before adding 1.25 µL ethidiumbromide (final concentration: 0.5 µM).
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The mixture was poured into the gel chamber and after congealing covered with TAE-
buffer. The DNA-samples were mixed with 10Ö sample buffer and filled into the gel
slots. DNA fragments were separated by applying a potential of 70 Volt and a current
of 180 mA for 30 min. The gels were UV-exposed and photo-documented.
Solutions
TAE-buffer
(Tris-acetate-EDTA-buffer) Tris 40 mM
sodium acetate 20 mM
EDTA 1 mM
adjust pH to 8.2 with acetic acid
10Ö sample buffer
saccharose 70% (w/v)
bromophenol blue 0.25%
EDTA (pH 7.5) 0.1 M
2.5.8 DNA-sequencing
Plasmids were checked for correct insert sequence prior to further usage. DNA sequenc-
ing was carried out by the company GATC Biotech, Konstanz.
2.6 Protein biochemistry
2.6.1 SDS polyacrylamide gel electrophoresis
Protein mixtures were analyzed by SDS polyacrylamide gel electrophoresis (SDS-PAGE).
Minigels containing 15% acrylamide were used. Samples were mixed with 8Ö sample
buffer and boiled for 5 min at 96. Gels were run in SDS running buffer in mini-gel
boxes (BioRad) for 45 min at a constant current of 40 mA per gel. Gels were either
used in Western blots or stained with Coomassie.
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Solutions
8Ö SDS-sample buffer
SDS (10%) 16 mL
glycerol (87%) 4 mL
Tris/HCl (0.5 M, pH 6.8) 2.2 mL
β-mercapto ethanol 200 µL
bromophenol blue a pinch
acrylamide solution
acrylamide 30% (w/v)
N,N-methylenbisacrylamid 0.8% (w/v)
stacking gel
(4%, for 4 gels)
water 4.5 mL
0.5 M Tris/HCl (pH 6.8) 1.9 mL
SDS (10%) 75 µL
APS (24% (w/v)) 30 µL
TEMED 15 µL
resolving gel
(15%, for 4 gels)
water 1.6 mL
Tris/Base (pH 8.8) 7.4 mL
acrylamide solution 10 mL
SDS (10%) 200 µL
APS (25% (w/v)) 80 µL
TEMED 20 µL
2.6.2 Coomassie staining of SDS-gels
Gels were incubated thoroughly (30 min to overnight) in staining solution, and then
transferred into destaining solution until clear distinction of protein bands versus back-
ground was possible. Thereafter gels were incubated overnight in drying solution. For
conservation, protein gels were dried between cellophane foils (Gel Air Cellophane Sup-
port, BioRad).
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Solutions
Coomassie stain
Coomassie R-250 0.25% (w/v)
ethanol 30% (w/v)
acetic acid 10% (v/v)
Destain
ethanol 40% (v/v)
acetic acid 10% (v/v)
water 50% (v/v)
Drying solution
methanol 50% (v/v)
glycerin 3% (v/v)
water 47% (v/v)
2.6.3 Inoculation of bacterial cultures
250 mL LB-Amp-Cm-medium were inoculated with a colony of transformed bacteria
and incubated overnight at 37. A portion of this was added to 2 L fresh LB-Amp-
Cm-medium, to yield an absorption of OD600=0.1. The bacterial culture was incubated
at 37 up to an absorption of OD600=0.8. The culture was cooled to 20 to slow
down protein production and gene expression induced by adding IPTG (isopropyl βD-
thiogalactopyranoside, end concentration 0.1 mM). Bacteria were shaken overnight at
20 and 120 rpm in an incubator (Infors Af 110, Infors AG).
2.6.4 Harvest and lysis of E. coli cells
The following steps were performed on ice. The bacterial cultures were centrifuged for
15 min at 6’000Ög . The supernatant was discarded and the cell pellets were resus-
pended in 50 mL resuspending buffer containing 100 µL 0.5 M EDTA, one protease
inhibitor cocktail tablet “Complete” (Roche) and 5 µL benzonase. The cells were dis-
rupted using a French Press. The suspension was centrifuged 1 h at 39’800Ög. The
supernatant containing the soluble protein of interest was carefully separated from the
pellet. The pellet was resuspended in one volume 8 M urea, corresponding to the vol-
ume of the soluble fraction, and a sample centrifuged. 5µL of both supernatants were
analyzed in SDS-PAGE.
2.6.5 Affinity chromatography with glutathione-sepharose
The centrifuged supernatant was incubated with 10 mL of glutathione-sepharose (Amer-
sham Biosciences) for 1 h at 4. The suspension was poured into a glas column with
frit that was connected to a peristaltic pump and flow-through photometer (OD280).
The sepharose was washed with PBS (Nck1-SH2) or washing buffer (Nck2-SH2) un-
til the OD280 corresponded to the buffer absorption. The fusion protein was eluted
by stepwise incubation on ice with elution buffer (total of 150 mL). 100 µL (200 U)
PreScission protease (Amersham Biosciences) was added to the solution to cleave the
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fusion construct. The protein solution was filled into a wetted dialysis tube and dial-
ysed overnight against at least 20 volumes of IEC buffer (Nck1-SH2) or gelfiltration
buffer (Nck2-SH2) at 4. Samples of all steps were analyzed by gel electrophoresis.
Solutions
Washing buffer Nck2
Tris/HCl (pH 8.0) 25 mM
NaCl 200 mM
Elution buffer
Tris/HCl 25 mM
NaCl 200 mM
glutathione, reduced 20 mM
adjust pH to 8.0 with NaOH
IEC buffer Nck1
sodium citrate (pH 6.0) 25 mM
Gelfiltration buffer Nck2
Tris/HCl (pH 8.0) 25 mM
NaCl 200 mM
2.6.6 Ion exchange chromatography
Ion exchange chromatography was only applied during purification of Nck1-SH2. The
protein solution obtained from affinity chromatography was dialysed and loaded onto
a cationic exchange column (MonoS, Pharmacia) equilibrated with low salt buffer. The
protein was eluted with a gradient from 0 M to 1 M NaCl in a volume of 50 mL
with a flow rate of 1 mL/min. Fractions (2 mL) were collected and OD280 measured.
Fractions absorbing stronger than buffer were analyzed by gel electrophoresis, pooled
if appropriate and stored at 4.
Solutions
Low salt-buffer
Sodium citrate (pH 6.0) 25 mM
High salt-buffer
Sodium citrate (pH 6.0) 25 mM
NaCl 1 M
2.6.7 Gelfiltration
Protein solutions were concentrated prior to gelfiltration to 5-10 mL and filtered (0.45
µM pore diameter). Each protein solution was applied to a gelfiltration column (Superdex-
75 16/60 (5mL) or 26/60 (10 mL)) equilibrated with the appropriate gelfiltration buffer.
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Proteins were separated with one column volume buffer (120 mL or 340 mL) with a
flow rate of 0.5 to 1 mL/min and sampled in 2 mL steps. Samples with higher OD280
absorption were analyzed via SDS-gel electrophoresis.
Nck1-SH2 and Nck2-SH2 were dialyzed against sodium citrate (pH 6.0, 25 mM) and
Tris/HCl (pH 8.0, 25 mM), respectively, with 1 mM DTT each.
Solutions
Gelfiltration buffer Nck1
Sodium citrate (pH 6.0) 25 mM
NaCl 200 mM
Gelfiltration buffer Nck2
Tris/HCl (pH 8.0) 25 mM
NaCl 200 mM
2.6.8 Determination of protein concentration by absorption
spectroscopy
The absorption of 0.5 mL of a protein solution diluted 1:10 using buffer was measured at
280 nm against the corresponding buffer solution. By applying the calculated extinction
coefficient (Gill & von Hippel, 1989), the absorption and the dilution factor, the protein
concentration was determined according to the Lambert-Beer equation (eq. 2.1).
c =
MW
εd
A280 (2.1)
c: concentration [mg/mL]
MW: molecular weight [mg/mmol]
ε: calculated molar extinction coefficient[M−1cm−1]
d: layer thickness of cuvette
The theoretical extinction coefficient of Nck1-SH2 and Nck2-SH2 is 12090 and 12210
M−1cm−1, respectively.
2.6.9 Concentration of protein solutions
Protein solutions were concentrated by ultracentrifugation using Viva-Spin-concentra-
tors (Vivascience) according to the manufacturer’s instructions.
2.6.10 In vitro translation of proteins
In vitro translation was performed using the RTS 100 E. coli HY Kit (Roche) (50
µL reaction volume) and the RTS ProteoMaster Instrument (Roche) according to the
manufacturer’s instructions.
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2.7 Immunological methods
2.7.1 Western blot
To transfer proteins from an SDS-gel onto a PVDF-membrane, the gel was equilibrated
in transfer buffer for 10 min. The PVDF-membrane was activated in methanol for 2
min and then also equilibrated in transfer buffer. A Whatman-paper soaked in transfer
buffer, the PVDF-membrane, the SDS-gel and finally the second soaked Whatman-
paper were layered onto the cathode of the semi-dry blotting chamber. The transfer of
protein bands was carried out for 18 min applying a voltage of 15 Volt.
The membrane was blocked in 5% milk powder in PBS for 30 min followed by incu-
bation with the primary antibody overnight at 4. The membrane was washed 3Ö
with PBS and incubated with a secondary antibody at 4 (A4a, 1 : 2000-dilution) for
2 h, if necessary for staining. After 3Ö washing with PBS, the blot was stained with
chlornaphthol or the ECL-Kit solution (Roche).
Solutions
Transfer buffer
Tris-base 25 mM
glycine 192 mM
methanol 15%
Staining solution
PBS 47 mL
chlornaphthole solution 3 mL
(0.3% in methanol)
hydrogen peroxide 25 µL
(30%)
2.7.2 Epitope scan
Epitope scans may be used to determine the influence of amino acid residues in a
peptide on the binding affinity of a protein. Amino acids from a peptide are mutated
one by one into all possible 20 amino acids. These peptide analogues are spotted onto
a membrane which then is incubated with the protein of interest. Antibody staining of
the protein and thereby estimating the relative binding affinity allows the identification
of amino acid preferences.
The peptides were synthesized and spotted onto a cellulose membrane by R. Frank,
GBF.
The membrane was soaked in ethanol until white spots (undissolved peptides) were no
longer visible. The membrane was then washed for 10 min in 10 mL TBS and incubated
in 10 mL MBS overnight. It was washed once with 10 mL T-TBS and incubated with
a 1 mg/mL GST-Nck-solution diluted 1:200 in 8-10 mL MBS for 2-4 h and washed 3Ö
with 10 mL T-TBS. The membrane was again incubated with a GST-HRP antibody
conjugate diluted 1:5000 in 8-10 mL MBS for 1-2 h. After twice washing for 10 min
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with 10 mL T-TBS, the blot was stained using the ECL Kit (Amersham Biosciences).
The membrane was enwrapped in plastic to prevent dessication.
To reuse the peptide membrane, both GST-Nck and the antibody had to be removed
quantitatively. For this purpose, the membrane was washed 3Ö for 10 min in 20 mL
water, 3Ö for 10 min in 20 mL SM-A and finally 3Ö for 10 min in 20 mL SM-B.
After 3Ö washing in ethanol, the membrane was either directly reused in the process
described above or air-dried and stored at -20.
The membrane was first tested for unspecific peptide binding using GST alone. The
experiment itself was repeated 3Ö using both GST-Nck1-SH2 and GST-Nck2-SH2 and
two identical peptide membranes. The luminescence intensity of each spot was quan-
tified using the program AIDA 3.5 (Raytest GmbH). The raw values were normalized
by dividing by the average value of all positive controls from one experiment. For
each peptide, the values of the 3 experiments were averaged and visualized using Corel
PRESENTS 6 (see appendix B and Fig. 3.30). The standard error of the mean (SEM)
was calculated for each spot. To give an impression of the reliability of the data, all
SEMs of a peptide position were averaged and shown below each column in Fig. 3.30.
Averaged data and SEM for each spot are listed in the appendix.
Solutions
TBS
NaCl 8.0 g
KCl 0.2 g
tris-base 6.1 g
water fill up to 1 L
adjust pH to 7.0 with HCl and autoclave
T-TBS
TBS
Tween-20 0.05%
MBS
Genosys blocking reagent 2 mL
T-TBS (pH 8.0) 8 mL
saccharose 0.5 g
adjust pH to 7.0
SM-A
urea 8 M
SDS in PBS 1%
β-mercapto ethanol 0.5%
adjust pH to 7.0 or 8.0 with acetic acid
SM-B
acetic acid 10%
ethanol 50%
water 40%
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2.8 Analytical methods
2.8.1 Dynamic light scattering
Dynamic light scattering allows the translation diffusion coefficient of a protein to be
determined. Assuming the molecule to be globular allows to estimate the hydrodynamic
radius (eq. 2.2) and hence the molecular weight of the protein.
Rh =
kT
D6piη
(2.2)
Rh: Hydrodynamic radius
k: Boltzman constant
T : Temperature
D: Diffusion coefficient
η: Dynamic viscosity
Protein solutions (concentration 6 to 10 mg/mL) were centrifuged at 20’800Ö g for 10
min prior to the DLS experiment. Measurements were performed using a DynaPro-
801 (ProteinSolutions) analyzer and interpreted by the evaluation software Dynamics
(version 5.26.38, ProteinSolutions).
Table 2.4: Interpretation of dynamic light scattering data according to the man-
ufacturer’s guide-lines.
Parameter Data Interpretation
Rh/Molecular mass degree of oligomerization
Polydispersity < 15% monodisperse solution
> 15% polydisperse solution
Baseline 0.997-1.001 monomodal particle distribution
1.002-1.005 monomodal,
minor occurence of bigger particles
> 1.005 polydisperse solution
SOS-error 1.0-5.0 negligible error
5.0-20.0 significant background error
due to solvent effects
or minor polydispersity
> 20.0 huge error
due to major polydispersity
2.8.2 Surface plasmon resonance spectroscopy
SPR spectroscopy allows the real-time detection of biomolecular interactions (Fager-
stam et al., 1992; Silin et al., 1997). Based on the physical effect of surface plasmon
resonance, alterations in the optical density on the surface of a gold chip can be mea-
sured. A molecule (ligand) is coupled to this surface and the interacting molecule
CHAPTER 2. MATERIALS AND METHODS 38
(analyte) is passed over the chip. Binding of the analyte to the ligand induces a change
in optical density which is detected. The method is especially suitable for analyzing
1:1 interactions like in this study. Additionally, coupling a peptide instead of a protein
to the chip surface avoids potential problems as no tertiary structure of the ligand can
be destroyed during recovery of the chip surface between analyzes.
Surface plasmon resonance experiments were performed using a BIACORE 2000 (BIA-
CORE AB). Biotinylated peptides were passed over the surface of a streptavidin-coated
sensor chip (SA5, Pharmacia Biosensor) until a suitable coating level was achieved. The
machine temperature was maintained at 25, and a flow rate of 10 µL/min was ap-
plied. Nck1-SH2 and Nck2-SH2 were diluted in standard HBS-EP buffer also used as
running buffer. A dilution series of each protein was prepared, in the range of 1 mM
to 10 nM. For each concentration, protein binding was followed for 2 min and disso-
ciation for another 2 min. The protein was eluted between injections and the surface
regenerated with 10 µL of 1 M NaCl. The experiments were performed in triplicate.
Sensorgrams for each protein concentration, after subtraction of the reference surface
sensorgram, were overlaid and aligned to the same baseline. The sensorgram data were
quantified by thermodynamic analysis. The resonance at equilibrium for each concen-
tration was plotted against the protein concentration. The binding constant KD was
determined by fitting a curve to this plot and assuming a 1:1 binding isotherm.
Solutions
HBS-EP
Hepes 10 mM
NaCl 150 mM
EDTA 3 mM
Tween20 0.005%
adjust pH to 7.4
2.8.3 Mass spectrometry
The protein solution to be analyzed was dialysed against a suitable salt free buffer.
Mass spectrometry was performed by Jacqueline Majewski, GBF, using an ultraflex
TOF/TOF mass spectrometer (Bruker).
2.8.4 N-terminal sequencing
Proteins were separated by SDS-gel electrophoresis and thereafter blotted onto a PVDF-
membrane (see section 2.7.1). The PVDF-membrane was shortly incubated in Coomassie-
staining solution to visualize the protein bands. The bands of interest were dissected
and given to Rita Getzlaff, GBF, who performed the N-terminal sequencing according
to the method of Edman (Edman & Begg, 1967).
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2.8.5 Isoelectric focussing
The isoelectric focussing was performed using commercially available PhastGels IEF 3-9
(Amersham) in a PhastSystem (Amersham) according to the manufacturers’ instruc-
tions. BSA was used additionally as standard (pI= 4.7). Experiments were performed
by Tobias Marquardt as part of his diploma thesis.
2.9 Pull-down assay
A431 (ATCC, CRL 1555) cells and HeLa S3 cells (CCl-2.2) were maintained as recom-
mended by the supplier (ATCC, LGC Promochem, Wesel, Germany). 10 cm diameter
dishes of 70% confluent cells were starved by serum deprivation for 24 h and sub-
sequently treated with DMEM containing or not 2 M TPA (Phorbol 12-myristate
13-acetate) for 10 minutes at 37. After stimulation of protein phosphorylation, cells
were lysed in 500 µL icecold lysis buffer for 10 min on ice, harvested with a cell scraper
and the lysate was cleared at 15’000Ö g for 15 min at 4. Lysates were incubated
with 25 µL glutathione sepharose loaded with GST alone or GST-SH2 domains of ei-
ther Grb2, Nck1 or Nck2 and incubated for 1 h at 4 on a rotary wheel. Precipitates
were washed twice, resolved by SDS-PAGE and analyzed by immunoblotting using an
α-GIT1 antibody (Santa Cruz Biotechnology, USA).
Solutions
Lysis buffer
Tris 12 mM
Hepes (pH 7.4) 16 mM
NaCl 50 mM
KCl 15 mM
NaF 20 mM
Na3VO4 1 mM
adjust pH to 7.4
2.10 Crystallization
Commercially available screens in combination with sitting drop crystallization were
used to identify initial crystallization conditions.
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Product Company
Additive Screen I,II,III Hampton Research
Crystal Cryo Hampton Research
Crystal I and II Hampton Research
Index I and II Hampton Research
PEG Ion Hampton Research
PEG 6000/LiCl Hampton Research
Sodium Malonate Grid Screen Hampton Research
Grid Screen Amino Sulfate Hampton Research
Crystal Screen Lite Hampton Research
Cryo I and II Emerald Biostructures
Wizard I and II Emerald Biostructures
Jena Biosciences Kits 1 to 10 Jena Bioscience GmbH
2.10.1 Sitting drop crystallization
50-100 µL crystallization buffer were pipetted into the reservoir wells of a 96-well
crystallization plate. 1-3 µL reservoir solution and an equal amount of protein solution
were mixed in the sample well. The plate was sealed with CrystalClear-tape and
incubated at 4, 12 or 20. The drops were checked for crystals after a week.
2.10.2 Hanging drop crystallization
The wells of a 24-well crystallization plate (Hampton Research) were filled with experiment-
dependent reservoir solutions. The crystallization drop was pipetted onto a siliconized
cover slip. 1-3 µL protein solution was mixed with an equal amount of reservoir solution
plus 1 µL additive where required. The rim of each well was greased with silicon oil and
the inverted cover slips placed onto the wells to seal it. The solutions were incubated
at either 4 or 20 and checked for crystals after a few days to one week for the first
time, and thereafter on a weekly to monthly basis.
2.11 X-ray analysis
2.11.1 Cryo-cooling of crystals
To collect X-ray diffraction data, the protein crystals were cryo-cooled in liquid nitro-
gen and maintained at this temperature. As a first step, a suitable cryo-solution was
identified by mixing 80% (by volume) mother liquor with 20% cryo-protectant con-
sisting of saturated sugar solutions, low molecular weight PEGs or alcohols. The cryo-
solution was checked for precipitation or phase separation and the cryo-concentration
was adjusted as necessary. Test crystals were transferred to cryo-protectant solutions,
retrieved after varying times (a few seconds to a minute) using a nylon loop of ap-
propriate size and rapidly plunged into liquid nitrogen. The cryo-cooled crystals were
transferred onto the goniometer using either a cap tube filled with liquid nitrogen or
a pre-cooled cryo-tong. The crystal was maintained at cryogenic temperatures (100
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K) throughout the data collection by a constant stream of nitrogen produced by a
CryoStream (Oxford Cryo Systems). Coincidentally, the reservoir solutions of all crys-
tals finally used for data collection did not require the addition of cryoprotectants. As
a result, crystals could be directly cryo-cooled in their mother liquor.
2.11.2 Data collection
Crystal quality was checked using a home X-ray source consisting of an RU-H3R ro-
tating copper anode generator (Rigaku MSC) and an Osmic confocal mirror system
(Rigaku MSC), required to monochromatize and focus the CuKα radiation (λ = 1.54
A˚). Diffraction patterns were recorded using an R-AXIS IV++ image plate detector
(Rigaku MSC).
Full data sets were collected at the BESSY (BL2, Berlin) and DESY (BW6, Hamburg)
synchrotrons.
2.11.3 Data evaluation
The HKL program package (Otwinowski & Minor, 1997) consisting of three programs
was used for data evaluation and reduction.
XDISPLAYF
The program displays diffraction images and allows reflections to be identified. It fur-
thermore allows automatic indexing solutions and the refinement to be inspected opti-
cally by DENZO.
DENZO
Using the reflections identified by XDISPLAYF and geometric and experimental pa-
rameters supplied by the user, DENZO is able to identify the unit cell and provide
a correlation of the observed diffraction pattern with all Bravais lattices. Further im-
provement of the correlation is achieved by refining the crystal unit cell and the physical
parameters of the experiment.
SCALEPACK
SCALEPACK scales diffraction images relative to each other to account for irregular
crystal shape and varying exposure doses. Partial reflections from adjoining images are
added and finally symmetry related reflections are merged to yield the set of unique
reflections. The completeness of the data set and the multiplicity of the reflections in
shells of resolution is tabulated. The linear Rsym (eq. 2.3) for every resolution shell
and the average intensity and average error quotient allow the data set quality to be
assessed.
Rsym =
∑
n |Ihkl(n) − 〈Ihkl〉|∑
n |Ihkl(n)|
(2.3)
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Ihkl(n): Intensity of hkl-reflection detected for the n
th time
〈Ihkl〉: Average intensity of the reflection hkl
The χ2 distribution (eq. 2.4) provided by SCALEPACK allows the intensity error in
every resolution shell to be estimated. χ2 should reach a value of approximately 1.
χ2 =
∑
n |Ihkl(n) − 〈Ihkl〉|2∑
nE
2 n
n−1
(2.4)
E: Estimated average error of intensities
Reflection intensities are converted into structure factor amplitudes using the program
TRUNCATE from the CCP4 program package (CCP4, 1994).
2.11.4 Molecular replacement
The method known as molecular replacement may be employed to calculate initial
phases for a data set if the tertiary structure of a related molecule (phasing model)
is already known. In principle, the phasing model is rotated and translated in space
so that the pattern of intramolecular vectors (rotation) and intermolecular vectors
(translation) (Patterson maps) correlates with that of the unknown structure. The
phases corresponding to the best model are used for a first structure solution.
2.11.5 Structure refinement
Several methods may be used to refine a model structure. Least-squares refinement
traditionally seeks to minimize the error squares of the atomic coordinates. A disad-
vantage of this method is the limited radius of convergence. Therefore, especially at
the beginning of a refinement, simulated-annealing (Kirkpatrick et al., 1983) where the
protein structure is virtually heated up to 2500 K and slowly cooled down in steps of
100 K is considerably more efficient. This allows local energy minima to be overcome,
increasing the convergence radius significantly.
CNS (Bruenger et al., 1998) was used in the beginning of structure refinement, com-
bining simulated annealing and a bulk solvent correction. The latter allows for the
improved incorporation of solvent filled regions. During later stages of refinement, the
program REFMAC (Murshudov et al., 1997) was used especially to model disordered
side chains, to find water molecules and to incorporate TLS refinement, which allows
for the incorporation of domain movements.
2.11.6 Model building
Manual model building between automated cycles of refinement helped significantly in
matching the model to the electron density. Visualization of the electron density and
the molecular model was performed using the program O (Jones et al., 1991) on Silicon
Graphics and Linux workstations.
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2.11.7 Quality of structures
Crystallographic R-factor and free R-factor
The major criterion for the quality assignment of a structure is the crystallographic
R-factor (eq. 2.5). It compares calculated Fcalc,hkl with measured structure factor am-
plitudes Fobs,hkl (eq. 2.5).
R =
∑
hkl ||Fobs,hkl| − |kFcalc,hkl||∑
hkl |Fobs,hkl|
(2.5)
However, as this value is greatly affected by the refined parameters (model bias), it
has been complemented by the free R-factor (Bruenger, 1992). For this purpose, 5%
of measured structure factor amplitudes are reassigned at random to a “test set” that
is excluded from refinement. Applying eq. 2.5 to the test set allows the free R-factor to
be calculated. The free R-factor is generally higher than the crystallographic R-factor.
Both should decrease during model refinement. A free R-factor below 45% indicates
a partially correct structure that may be worthwhile to refine. A free R-factor below
25% can be taken to represent a structure that is essentially correct.
Ramachandran-Plot
A stereochemical analysis is a second important criterion to assess the quality of a
protein structure. The main chain dihedral angles φ and ψ of the amino acids appear
in characteristic combinations in different secondary structures due to their stereo
chemistry (Ramachandran & Sasisekharan, 1968). As the dihedral angles other than
ω-angles are not restrained during refinement, a reasonable protein model should have
most values of φ and ψ in the energetically most favoured region. φ is plotted against ψ
in the Ramachandran plot allowing the rapid evaluation of the backbone conformation.
The plot can be automatically generated by programs PROCHECK (Laskowski et al.,
1993) and WHAT IF (Vriend, 1990).
2.11.8 Figure preparation
Structures were graphically presented using either the program PyMOL (DeLano,
2002) or a combination ofMOLSCRIPT (Kraulis, 1991), BOBSCRIPT (Esnouf, 1999),
RASTER3D (Merritt & Murphy, 1994). The program GRASP (Nicholls et al., 1993)
was used for calculating electrostatic surfaces. Figures were optimized usingGL-RENDER
and PovRay. Secondary structure was calculated using STRIDE (Frishman & Argos,
1995).
2.11.9 Structure based sequence alignment
Sequences of structures were aligned manually by superposition of SH2 domains using
LSQKAB (CCP4, 1994). Alignments were displayed using ESPript (Gouet et al., 1999).
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Chapter 3
Results
3.1 Cloning, expression and purification
Crystallization of proteins may easily require up to 100 mg of material. The simplest
and most economical method to obtain such a large amount of protein is recombi-
nant production in E. coli. Large-scale production of any of the proteins of interest
had not been published at the time, requiring appropriate production protocols to be
established.
3.1.1 Virulence factor Tir of enteropathogenic E. coli
The virulence factor Tir (TrEMBL accession number: O52147) is a 57 kDa (550 aa)
type III transmembrane protein with the cytoplasmic part composed of the N- and
C-termini and an extracellular central stretch (Hartland et al., 1999). The C-terminal
cytoplasmic domain (162 aa, 17 kDa) bears the critical Tyr474 that is phosphorylated
during EPEC infection and recruits the human adapter protein Nck (Fig. 3.1).
Figure 3.1: Domain structure of Tir. TM– transmembrane helix; cytoplasmic – part of
Tir located in the host cytoplasm; extracellular – part of Tir located extracellularly.
The C-terminal cytoplasmic part of the tir gene (corresponding to aa 389-550) was
amplified directly from genomic DNA of lysed EPEC cells using PCR. The resulting
fragment was cloned into the expression vectors pQE-60 and pGEX-6P-1, both of which
are inducible by IPTG and express the protein of interest with N-terminal His- and
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GST-tag, respectively. The fusion tags allow for easy purification of Tir by affinity chro-
matography. The linker between GST and Tir contains a Prescission protease cleavage
site for easy removal of GST following affinity chromatography. The plasmids were
introduced into two different E. coli strains (BL21 CodonPlus and M15). The BL21
CodonPlus strain contains an additional plasmid with chloramphenicol resistance en-
coding rare tRNAs. The enlarged tRNA-pool can prevent lack of certain tRNAs and
thereby increase the total amount of produced protein. The production of His- and
GST-Tir fusion proteins was tested at 20 and 37, using different E. coli clones and
monitored at several time points.
His-Tir protein could not be detected in Coomassie stained SDS-gels or α-His-western
blots at any condition using the pQE vector. Expression tests with pGEX6-P-1-Tir
yielded sufficient fusion protein for visualization in a western blot using α-GST anti-
body (Fig. 3.2) though the protein could not be seen in Coomassie stained SDS-gels.
The presumed GST-Tir protein appears at 50 kDa, somewhat higher than expected
for a molecular mass of 43 kDa. The production quantity was low and the protein was
very unstable. It had been degraded completely after overnight induction. A second
clone containing pGEX-6P-1-Tir produced a band at 30 kDa, presumably attributable
to GST alone. To exclude a frame shift or a cloning error, both expression vectors were
resequenced and checked for mutations. Errors were not detected, indicating that the
isolated C-terminal domain is instable.
Figure 3.2: Expression of pGEX-6-P1-Tir in E. coli BL21 CodonPlus. The α-GST
western blot shows GST-fusion protein production after IPTG-induction at 20.
Degradation may be due to poorly folded parts in a protein. Therefore, analyzing the
prediction of the secondary structure and folded parts of Tir should indicate constructs
that possibly could prove to be less prone to degradation. The secondary structure pre-
diction and prediction of disordered regions by the internet service PONDR (Fig. 3.3,
Romero et al. (2001)), however, did not give hints for protein parts likely to be stable.
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Most parts of the Tir construct are predicted to lack secondary structure elements
like α-helices or β-strands and contain a high percentage of hydrophilic amino acids.
Likewise, most residues are assigned as unstructured, giving a possible explanation for
the instability of the protein in the expression tests performed.
Figure 3.3: Prediction of disordered regions in Tir389−550. A PONDR score above 0.5
indicates a potentially disordered residue. The black bar shows parts that are particularly
likely to be disordered.
Hence, as an alternative, production of the vaccinia virulence factor A36R was under-
taken.
3.1.2 Virulence factor A36R of vaccinia virus
A36R (TrEMBL accession number: P68619) is an outer membrane protein of vaccinia
virus comprising 221 amino acids (25 kDa). The N-terminal 25 residues constitute a
transmembrane anchor while residues 26-221 are exposed to the cytoplasm of the host
cell (Fig. 3.4).
Figure 3.4: Domain structure of A36R. TM– transmembrane helix; cytoplasmic – part
of A36R located in the host cytoplasm.
The DNA sequence encoding this C-terminal part was amplified from purified genomic
DNA and cloned into the vectors pGEX-6P-1, pETM-10, pETM-30 and pETM-41. The
pETM-10, -30 and -41 vectors are coding for His-A36R, GST-A36R and MBP-A36R
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(maltose binding protein), respectively. Each vector was transformed into several E. coli
strains and expressed at varying conditions.
Both at 20 and 37 pGEX-6P-1-A36R in E. coli BL21 CodonPlus produced protein
in high amounts that was stained by an α-GST antibody in a Western blot (Fig. 3.5).
Significant degradation of the protein was observed. In addition, the apparent molecular
mass of the GST-A36R fusion at 70 kDa was 20 kDa larger than expected. Checking
the DNA-sequence confirmed the construct to be correct but N-terminal sequencing
of the protein band revealed a sequence that does not correspond to GST nor A36R.
Instead, a BLAST search indicates that this sequence belongs to the chaperone dnaK
from E. coli. As dnaK comprises 637 amino acids, the molecular weight of ∼ 70 kDa in
the SDS-gel seems feasible.
Figure 3.5: Expression tests of pGEX-6P-1-A36R. The α-GST western blot presumably
shows production of the chaperone dnaK after IPTG-induction.
As the expression of pGEX-6P-1-A36R yielded contradictory results, various clones
of pETM-10-, -30- and -41-A36R were tested. pETM-30-A36R, also coding for GST-
A36R, was chosen as control for pGEX-6P-1. The plasmids were again checked for
correct sequence. Expression tests with all plasmids were performed at 22 and 37.
Different E. coli strains were tested (BL21 CodonPlus, Rosetta, Star pLysS). All strains
may reduce protein degradation in the cytoplasm as they lack the La protease previ-
ously identified to be responsible for most proteolytic activity (Gottesman, 1990). BL21
CodonPlus and Rosetta moreover may prevent a lack of suitable tRNAs as they con-
tain a plasmid encoding for rare tRNAs in E. coli. The strain Star pLysS was chosen
additionally as it does not produce RNaseE that is responsible for most degradation
of mRNA (Coburn & Mackie, 1999). However, none of them produced A36R in de-
tectable amounts by Western blotting. Possibly, A36R could be toxic to E. coli pre-
venting efficient protein production and E. coli growth, but monitoring the cultures
during expression did not indicate suppressed bacterial growth.
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As A36R could not be produced in E. coli, in vitro translation was attempted using
the vectors pETM-10- and pETM-30-A36R that encode for His- and GST-A36R, re-
spectively. Both plasmids contain a T7-promoter required for the in vitro expression
system. Expression of the gene for GST-A36R produced no suitably sized protein. His-
A36R, however, produced an A36R band that only weakly stained in the Western blot
despite being visible in the SDS-gel possibly implying that the His-tag is not easily
accessible (Fig. 3.6). Attempts to bind the fusion protein to Ni-agarose failed. There-
after, the fusion protein could no longer be detected neither on the column nor in the
flow through.
Figure 3.6: In vitro translation of His-A36R. In the SDS-gel, an additional band is
visible which is stained in α-His western blot. His-GFP is shown as control. Expression tests
were stopped after 3.5 h or 6 h.
Analyzing the prediction of secondary structure and disordered regions as for Tir, like-
wise did not indicate a potentially more stable construct (Fig. 3.7). The C-terminal
part of A36R (residues 160 to the C-terminus) is more likely to be folded. The phos-
photyrosine necessary for interaction with Nck, however, is not located in that part,
thus such a construct would not be suitable for Nck –A36R interaction studies.
CHAPTER 3. RESULTS 49
Figure 3.7: Prediction of disordered regions in A36R26−221. A PONDR score above
0.5 indicates a potentially disordered residue. The black bar shows parts that are particularly
likely to be disordered.
As the experiments did not indicate further possibilities to improve E. coli production of
A36R and Tir, a decision was taken to henceforth work with synthetic phosphopeptides
containing the critical binding regions rather than with complete proteins. As strategy
for future protein production of A36R and Tir, it may prove useful to express the
proteins in eukaryotic cells e.g. in yeast or insect cells.
3.1.3 SH2 domains of human adapter proteins Nck1 and Nck2
Both Nck1 and Nck2 consist of four domains, three SH3 followed by a single SH2
domain. The SH2 domain has been shown to mediate the interaction of Tir with Nck
via Tyr474, thus it was needed if a complex of Nck with Tir-derived phosphopeptides
were to crystallized. An alignment of several SH2 domains and the Nck proteins (Fig.
1.8) indicated that residues 281 to 377 of Nck1 and 284 to 380 from Nck2 define the
domain boundaries. Both proteins were cloned into pGEX-6P-1 to produce them as
GST-fusion proteins.
Nck1-SH2 and Nck2-SH2 could both be produced as GST-fusion proteins in E. coli and
purified using chromatography methods as described below.
Nck1-SH2
Cells of an IPTG-induced over night E. coli culture were disrupted and soluble proteins
were separated from insoluble by centrifugation. Reducing the incubation temperature
from 37 to 20 increased the percentage of soluble protein from 10% to 50%. The
GST-fusion protein was separated from bacterial proteins by affinity chromatography
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using glutathione-sepharose. Most E. coli proteins were removed by thoroughly wash-
ing the sepharose. The major proportion of GST-Nck1-SH2 could be eluted from the
sepharose and cleaved into GST and Nck1-SH2 with Prescission protease over night
(Fig. 3.8).
Figure 3.8: Isolation of Nck1-SH2 from E. coli. The soluble protein fraction was incu-
bated with GST-sepharose and most E. coli proteins were removed through thorough washing.
The eluted fusion protein was cleaved over night into GST and Nck1-SH2.
GST and remaining impurities were removed using ion exchange chromatography and
gelfiltration. Anion exchange chromatography at pH 8.0 allowed Nck1-SH2 (pI 8.2) to
stick to the column while GST (pI 5.9) was eluted without binding (Fig. 3.9). Most
GST was hence separated from Nck1-SH2 in a single step.
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Figure 3.9: Anion exchange chromatography of Nck1-SH2. Separation of GST and
Nck1-SH2 was carried out at pH 8.0. Samples of fractions 16 to 25 of the ion exchange
chromatography are analyzed by SDS-gel electrophoresis.
A gelfiltration run following the ion exchange chromatography removed last impurities.
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Figure 3.10: Final purification of Nck1-SH2 by gelfiltration. Samples of fractions 16
to 18 of the gelfiltration are analyzed by SDS-gel electrophoresis.
Nck1-SH2 was dialysed against 10 mM citrate buffer at pH 6.0, concentrated to 10
mg/mL and stored at 4. A total of 3-6 mg Nck1-SH2 per liter of over night culture
was produced.
Nck2-SH2
The purification of Nck2-SH2 essentially followed the same protocol as that employed
for Nck1-SH2. The percentage of soluble fusion protein was somewhat higher than for
Nck1-SH2 at ∼ 70%. An affinity chromatography using glutathione-sepharose removed
E. coli proteins almost completely and Prescission protease digestion over 40 h cleaved
all fusion protein into GST and Nck2-SH2 (Fig. 3.11).
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Figure 3.11: Affinity chromatography of Nck2-SH2. After incubation of the soluble
protein fraction with glutathione sepharose and thorough washing, GST-Nck2-SH2 could be
eluted essentially purely from the sepharose. Prescission protease cleavage over 40 h separated
GST and Nck2-SH2.
A gelfiltration step was sufficient to separate GST and purify Nck2-SH2 completely
(Fig. 3.12).
Figure 3.12: Separation of Nck2-SH2 from GST and remaining impurities using
gelfiltration. Samples of fractions 21 to 45 of the gelfiltration are analyzed by SDS-gel
electrophoresis.
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Nck2-SH2 was dialysed against 20 mM Tris pH 8.0, concentrated to 5 mg/mL and
stored at 4. The protein yield amounted to 7-15 mg/L of culture.
3.2 Biochemical characterization of Nck1-SH2 and
Nck2-SH2
3.2.1 Stability of Nck1-SH2 and Nck2-SH2
Both Nck1-SH2 and Nck2-SH2 tended to precipitate over time. Nck2-SH2 precipitated
spontaneously above a concentration of 8 mg/mL. Lower concentrations were therefore
used for crystallization setups. Furthermore, storage at 4 caused about 30% of both
Nck1-SH2 and Nck2-SH2 to precipitate over several days. Significantly larger amounts
precipitated at room temperature. The pellet could not be dissolved by increasing
the ionic strength, diluting the protein solution or heating it up to 37. An FTIR
analysis of Nck1-SH2, however, revealed a significant stabilization through Tir-derived
phosphopeptides, the melting point rising from 42 without peptide to 68 in the
presence of a 10 amino acid peptide derived from Tir. Indeed, no further precipitation
could be observed if proteins were stored complexed to phosphopeptides.
To check whether precipitation was due to protein degradation, samples of Nck1-SH2
were analysed over three weeks by SDS-PAGE but no degradation was observed. This
observation was confirmed by MALDI-TOF mass spectrometry, which did not indicate
smaller fragments resulting from degradation (Fig. 3.13). In Table 3.1, the calculated
molecular weights and masses determined by MALDI-TOF are listed.
Table 3.1: Comparison of theoretical molecular mass and mass determined by
mass spectrometry. Mtheo – theoretical mass; MMALDI –mass according to MALDI-TOF.
Protein Mtheo [Da] MMALDI
Nck1-SH2 11730 11728
Nck2-SH2 11660 11642
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Figure 3.13: Mass spectrometry diagrams. No degradation products of Nck1-SH2 and
Nck2-SH2 could be detected. The additional larger peak (+ 208 Da) is a matrix adduct.
Phosphopeptides were hence added to the protein solutions as early as possible and
samples were kept at 4. Protein solutions were only concentrated to values neces-
sary for the following experiments. Before carrying out the experiments, samples were
centrifuged to remove traces of precipitate.
3.2.2 Oligomeric states of Nck1-SH2 and Nck2-SH2
Crystallization is critically dependent on the homogeneity of a protein solution. Nck1-
SH2 and Nck2-SH2 solutions were correspondingly analyzed for oligomerization or pro-
tein aggregation prior to crystallization.
Dynamic light scattering
The oligomeric state of both proteins was investigated by dynamic light scattering.
The data obtained showed the best correlation to a monomodal model revealing Nck1-
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SH2 and Nck2-SH2 to be a homogenous solution of monomeric proteins during the
experiment (Table 2.4, Table 3.2).
Table 3.2: Data of dynamic light scattering. Rh:hydrodynamic radius; MDLS –mass
according to DLS; SOS-error – sum of squares error.
Protein Rh [nm] MDLS [kDa] Polydispersity [%] Baseline SOS-error
Nck1-SH2 1.9 13.94 11.7 0.998 3.84
Nck2-SH2 2.0 14.85 11.5 0.998 2.52
Analytical gelfiltration
The oligomerization states of Nck1 and Nck2 SH2 domains were also investigated by
analytical gelfiltration. Using a calibration curve of known, globular proteins confirmed
the monomeric states of both Nck1-SH2 and Nck2-SH2 (Fig. 3.14).
Figure 3.14: Calibration curve of analytical gelfiltration. Ve –Elution volume; V0 –
Extinction volume; Mr –molecular mass; ADH– alcohol dehydrogenase; BSA–bovine serum
albumin.
Table 3.3: Comparison of theoretical molecular mass and mass determined by
gelfiltration. Mtheo – theoretical mass, MGPC –mass according to gelfiltration.
Protein Mtheo [Da] MGPC [Da] oligomerization
Nck1-SH2 11730 11280 monomeric
Nck2-SH2 11660 11880 monomeric
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3.2.3 Isoelectric point of Nck1-SH2 and Nck2-SH2
Figure 3.15 shows the silver stained SDS-gels of Nck1-SH2 and Nck2-SH2 after iso-
electric focussing. Nck1-SH2 exhibits two bands at pH 8.5 and 8.2. The theoretical
pI calculated from the amino acid sequence is 8.6. Only a single band is observed for
Nck2-SH2 at pH 6.8 near the theoretical pI of 6.5.
Figure 3.15: Isoelectric focussing of Nck1-SH2 and Nck2-SH2.
3.3 Nck1-SH2 and Nck2-SH2 binding affinities for
interaction partner derived phosphopeptides
Several human proteins have been reported to bind differentially to Nck SH2 domains
(Pramatarova et al. (2003); Cowan & Henkemeyer (2001); Chen et al. (2000), see chap-
ter 1.3.2). Therefore it was examined whether this also holds true for phosphopeptides
mimicking the binding sites of these interaction partners.
Binding affinities for phosphopeptides were quantified by surface plasmon resonance
(SPR) spectroscopy. Relative binding specificities for Nck1-SH2 versus Nck2-SH2 could
thus be inferred. The phosphopeptides used in the experiment were derived both from
interaction partners of pathogenic origin such as Tir and A36R, as well as from cel-
lular interaction partners such as platelet derived growth factor receptor (PDGFR),
Disabled-1 (Dab-1), ephrinB1 and ephrinB2. EphrinB1 and ephrinB2 share the same
binding site, referred to as ephrinB1/2 in the following. Dab-1 and PDGFR both bear
two independent phosphorylation sites, Tyr751 and Tyr1009 in PDGFR (PDGFR-Y751
and PDGFR-Y1009, respectively), and Tyr220 and Tyr232 in Dab-1 (Dab-1-Y220 and
Dab-1-Y232, respectively), resulting in a total of five peptides derived from cellular
interaction partners. Phosphopeptides were synthesized chemically, purified by HPLC
and checked by mass spectrometry (Werner Tegge, GBF). As the peptides were labelled
with biotin, they could be coupled to a streptavidin-coated Biacore chip surface. Serial
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dilutions of Nck1-SH2 or Nck2-SH2 were passed over the chip coated by Tir-derived
peptide (Fig. 3.16).
Figure 3.16: Sensorgrams of the Nck1-SH2 interaction with the Tir-derived phos-
phopeptide. A dilution series of eight Nck1-SH2 concentrations was passed over the Tir
phosphopeptide-coated sensor chip resulting in eight sensorgrams. A 1:1 binding model is
employed to fit calculated curves to the measured sensorgrams.
Analysis of the resulting sensorgrams yielded dissociation constants (KD) of 60 nM
for Nck1-SH2 and 370 nM for Nck2-SH2 (Table 3.4). As expected, unphosphorylated
Tir peptide (negative control) did not bind. Repeating the analysis for the A36R-
derived peptide, yielded dissociation constants of 59 µM and 150 µM for Nck1-SH2
and Nck2-SH2, respectively. The binding affinity of Nck1 and Nck2 SH2 domains for
the A36R-derived peptide is thus roughly three orders of magnitude weaker than for the
Tir derived peptide. Five phosphopeptides corresponding to cellular interaction part-
ners, Dab-1, PDGFR and ephrinB1/2 previously implicated in Nck-recruitment were
similarly analysed. Nck1-SH2 or Nck2-SH2 did not bind to three of the five peptides
(Dab-1-Y220, Dab-1-Y232, and PDGFR-Y751). The binding affinities for PDGFR-
Y1009 are 27 µM and 230 µM, and for ephrinB1/2 22 µM and 130 µM, respectively,
placing them in the same category as A36R and hence, again, roughly three orders of
magnitude lower than Tir.
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Table 3.4: Determination of binding constants for phosphopeptides of pathogenic
and human origin. NB–no binding detectable. Values in parentheses correspond to the
standard error of the mean (SEM) calculated from three independent experiments.
Peptide sequence Binding constant Binding constant
Nck1-SH2 [µM] Nck2-SH2 [µM]
Tir10 E-H-I-pY-D-E-V-A-A-D 0.06 (±0.01) 0.37 (±0.04)
Tir10 (unphosph.) E-H-I-Y-D-E-V-A-A-D NB NB
PDGFR-Y751 E-S-V-D-pY-V-P-M-L-D-M-K NB NB
PDGFR-Y1009 S-S-V-L-pY-T-A-V-Q-P-N-E 27 (±1) 230 (±60)
ephrinB1/2 C-P-H-pY-E-K-V-S-G-D 22 (±3) 130 (±50)
Dab-1-Y220 E-N-I-pY-Q-V-P-K-S-Q NB NB
Dab-1-Y232 E-G-V-pY-D-V-P-K-S-Q NB NB
A36R E-H-I-pY-D-S-V-A-G-S 59 (±9) 150 (±70)
In summary, the Tir-derived phosphopeptide is the only peptide binding with high
affinity. The other peptides are either low affinity interaction partners or even do not
bind to Nck SH2 domains. This was observed for both Nck1-SH2 and Nck2-SH2, thus no
difference in binding specificity can be inferred from SPR experiments. Despite similar
binding specificities, Nck1-SH2 always binds more tightly (2 – 9Ö) than Nck2-SH2.
3.4 Crystallization
Tobias Marquardt and Antje C. Findeis assisted in crystallization experiments as part
of their diploma theses. To investigate and potentially differentiate phosphopeptide
binding by Nck1-SH2 and Nck2-SH2 at the structural level, crystallization experiments
of both SH2 domains without and in complex with Tir-derived phosphopeptides were
set up. The Tir binding site was chosen as the affinity of Nck1-SH2 and Nck2-SH2 for
this peptide is 500-1000 times higher than for the other phosphopeptides tested (see
above).
3.4.1 SH2 domain of Nck1
Initial screening for crystallization conditions was carried out with commercially avail-
able screens. After seven days, crystals of the Nck1 SH2 domain were obtained in
30% PEG 5000 MME, 0.1 M MES pH 6.5, 0.2 M ammonium sulfate at 4. Test
screens at 12 and 20 were significantly prone to precipitation and yielded no
crystals. This confirmed the earlier observation that the Nck SH2 domains are partic-
ularly temperature-sensitive. Nck1-SH2 crystallized in bunches of thin needles (1 mm
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long, 0.01 mm thick) that were not suitable for X-ray analysis (Fig. 3.17). Variation
of PEG 5000 MME and ammonium sulfate concentration yielded single crystals that
diffracted to 4.1 A˚ at the home X-ray source (20% PEG 5000 MME, 0.1 M MES pH
6.5, 0.2 M ammonium sulfate). The crystals could be further improved through the use
of additives. Using guanidinium hydrochloride (normally classified as light chaotrope)
a significantly larger crystal form was obtained that diffracted X-rays to 3.0 A˚ using
the in-house equipment. Employing the significantly more intense radiation provided
by the synchrotron BESSY II (Berlin), the resolution could be extended to 1.8 A˚. A
complete data set to this resolution was hence collected.
Figure 3.17: Improving crystals of Nck1-SH2. Initial crystals grew as thin needles
originating at a common nucleation site (top left). They were up to 1 mm in length and 10
µm in width. Varying precipitant and salt concentrations yielded thicker single crystals (top
right). Additives acetonitrile (bottom left) and guanidinium hydrochloride (bottom right)
resulted in larger crystals with 0.8Ö0.2Ö0.2 mm3 and 0.4Ö0.15Ö0.15mm3, respectively.
3.4.2 SH2 domain of Nck2
Nck2-SH2 was initially crystallized in 40% PEG 400, 0.1 M MES pH 6.0, 5% PEG
3000 and 50% PEG 400, 0.1 M MES pH 6.0. The crystals diffracted X-rays to 2.1 and
3.5 A˚ resolution, respectively. However,the crystals were multiply twinned resulting in
split reflections (Fig. 3.18, left). A data set could thus not be collected. Crystallization
conditions were varied to improve the crystal quality. However, crystals could not be
reproduced using PEG 400. Replacing PEG 400 by PEG 550 MME produced crys-
tals but the resulting X-ray diffraction pattern could not be indexed, as the crystals
were still twinned producing blurred reflections. Varying the crystallization conditions
(precipitant concentration, temperature, protein concentration) and further employing
additives did not improve the diffraction pattern, nor did macro- and micro-seeding.
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Checking again all crystallization setups one year later, identified an unrelated crystal
form (Fig. 3.18, right) growing in 0.1 M bicine buffer pH 9.0, 2.4 M ammonium sulfate.
The crystals roughly resembled an American football with sharp edges along the longest
axis. The reflection pattern proved to be distinct and clear, allowing a data set to 2.8 A˚
resolution to be collected at beamline BW6 at the DESY synchrotron in Hamburg.
Figure 3.18: Crystals of Nck2-SH2. Crystals obtained after a few days (200Ö120Ö60
µm3, left) were visibly twinned and resulted in poor diffraction patterns despite diffracting
X-rays up to a resolution of 2.1 A˚. A second, unrelated crystal form was found one year later
(70Ö70Ö150 µm3, right) yielding useful X-ray data to 2.8 A˚.
3.4.3 Tir phosphopeptides complexed to Nck1-SH2 and Nck2-
SH2
Campellone et al. (2002, 2004) showed that a phosphopeptide consisting of 12 amino
acids surrounding Tyr474 in Tir is sufficient to recruit Nck and accumulate actin in
vitro. Therefore, both Nck1-SH2 and Nck2-SH2 were to be crystallized ideally with a
Tir-derived phosphopeptide of 12 amino acids. However, as the protein-peptide complex
mediates crystallization via its surface amino acids and thus the length of the peptide
may significantly influence crystallization, five phosphopeptides with varying lengths
of four to twelve amino acids were tested (Table 3.5, produced by W. Tegge, GBF).
Table 3.5: Tir-derived peptides crystallized with Nck1-SH2 and Nck2-SH2. Amino
acids are named by one-letter-code. The tyrosine corresponds to Tyr474 in Tir. “p” indicates
tyrosine phosphorylation.
Peptide sequence
Tir4 pY-D-E-V
Tir6 I-pY-D-E-V-A
Tir8 H-I-pY-D-E-V-A-A
Tir10 E-H-I-pY-D-E-V-A-A-D
Tir12 E-E-H-I-pY-D-E-V-A-A-D-P
Nck1-SH2 complexed to Tir12 was crystallized in cooperation with Yvette Roske, Pro-
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tein Structure Factory, Berlin. Crystals from initial screens (2.4 M di-ammonium hydro-
gen phosphate buffered with 0.1 M Tris pH 8.5) proved to be suitable for X-ray analysis
eliminating the need of further optimization (3.19, left). The cubic crystals were ob-
served to be sensitive towards all cryo-protectant solutions, breaking into pieces and
dissolving over time. As a result crystals were cryo-cooled in mother liquor sacrificing
some reflections obscured by thin water ice rings. Data were collected at DESY (BW6)
to 1.5 A˚.
Initial screens of Nck2-SH2 with several peptides yielded crystals. These, however,
were not suitable for X-ray data collection. Optimizing the crystallization conditions
produced diffraction-quality crystals only for Nck2-SH2/Tir8 (50% MPD, 12% ethanol
buffered with 0.01 M sodium acetate). Although not particularly regular, the crystals
diffracted to 1.5 A˚ at DESY (BW6).
Figure 3.19: Crystals of Nck1-SH2/Tir12 and Nck2-SH2/Tir8. The Nck1-SH2/Tir12
crystals (left) grew to 150Ö150Ö100 µm3 in size. Nck2-SH2/Tir8 crystals (right) measured
40Ö70Ö300 µm3. Appearances are deceptive: both crystals diffracted to 1.5 A˚.
3.5 Structure determination
3.5.1 Data set collection and evaluation
Data from crystals of ligand-free Nck1-SH2, the ligand-free Nck2-SH2, Nck1-SH2/Tir12
and Nck2-SH2/Tir8 were collected at the synchrotrons BESSY (BL2, Berlin) and DESY
(BW6, Hamburg). All crystals were cryo-cooled in liquid nitrogen directly from mother
liquor and measured at 100 K.
The diffraction pattern of each data set was indexed using XDISPLAYF (Otwinowski &
Minor, 1997) and DENZO (Otwinowski & Minor, 1997). The experimental parameters
were refined followed by reflection integration. The estimated positional errors were
monitored by χ2 distribution and appropriately adjusted. SCALEPACK (Otwinowski
& Minor, 1997) was used to scale images within a data set to merge symmetrically
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related reflections. The results of data collection and evaluation are summarized in
Table 3.6.
Table 3.6: Data collection statistics. Numbers in parenthesis correspond to highest
resolution shell. n.d. – could not be determined (see chapter 3.5.2).
Nck1-SH2 Nck2-SH2 Nck1-SH2/Tir12 Nck2-SH2/Tir8
Space group C222 P622 P212121 P212121
Unit cell lengths
a [A˚] 62.9 74.1 55.1 31.3
b [A˚] 82.5 74.1 60.5 58.2
c [A˚] 44.5 73.6 65.1 52.3
α [°] 90 90 90 90
β [°] 90 90 90 90
γ [°] 90 120 90 90
Molecules/asym.unit 1 n.d. 2 + 2 1 + 1
Resolution range [A˚] 50 - 1.8 50 - 2.85 30 - 1.4 50 - 1.45
Rsym [%] 4.8 (37.3) 10.0 (40.4) 4.3 (30.9) 4.3 (30.5)
I/σ(I) 34.3 (3.2) 11.0 (3.2) 28.1 (4.2) 25.1 (3.7)
Redundancy 6.1 (4.6) 2.8 (0.2) 4.0 (3.7) 3.3 (2.9)
Unique reflections 11’119 5’780 38’419 17’053
All data sets could be indexed and scaled without problems. Rsym and the ratio of re-
flection intensity to standard deviation I/σ(I) were used as quality criteria for indexing
and scaling. Rsym-values below ∼ 7% indicate an internally consistent data set. I/σ(I)
values of 3.0 or larger for the shell of highest resolution were accepted.
The diffraction pattern of the free Nck2-SH2 was found to consist of two superimposed
patterns. One of these was used to determine unit cell parameters and Bravais lattice.
Both diffraction patterns were separately evaluated and then merged to yield redundant
data. Weak water rings were visible but were ignored. The Rsym value was rather high
(10.0) possibly because two independent data sets were merged. The redundancy of
reflections rises with increasing resolution. Reflections at low resolution were generally
measured only once or twice possibly influencing the quality of the data set.
The other data sets did show no anomalies. In the data set of Nck1-SH2/Tir12, weak
water rings may marginally have diminished the data quality.
3.5.2 Structure solution and refinement
Ligand-free Nck1-SH2
To solve the structure of an unknown protein, the phases from a related molecule may
be taken as initial phases for electron density calculation (molecular replacement). The
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SH2 domain of Grb2, an Nck-related adapter molecule, was used in the molecular
replacement of ligand-free Nck1-SH2. The structure was solved with EPMR (Kissinger
et al., 1999). The best solution yielded a correlation coefficient of 24% and an R-factor
of 59%. The correlation coefficient was rather low and the R-factor too high for a correct
solution, but the resulting crystal packing checked in O was physically reasonable, and
thus refinement of the structure was started. The structure was first refined by rigid
body protocol using CNS (Bruenger et al., 1998), followed by simulated annealing
both of which allow for a particularly large radius of convergence. For this purpose,
the structure was heated to 2000 K in silico and slowly cooled down in steps of 100
K. REFMAC5 (Murshudov et al., 1997) was then used to further refine the structure.
Water was added to the structure automatically using ARP/WARP (Lamzin et al.,
2001). Cycles of automatic refinement were alternated with manual rebuilding the
model of ligand-free Nck1-SH2 to the (2Fo-Fc) electron density map in O (Jones et al.,
1991). Differences between model-derived and observed electron density were visualized
as difference (Fo-Fc) densities. Positive difference electron density was clearly visible
in the phosphotyrosine binding pocket of the ligand-free Nck1-SH2 structure. As a
phosphopeptide was not present in the crystals, the difference density was interpreted as
a SO2−4 ion. Furthermore, significant difference density near amino acid 336 (GluD’E1)
indicated a major difference between the model and the crystal, possibly explaining
the low correlation coefficient in molecular replacement. The difference density implied
that the loop D’E had straightened, thereby continuing on into the second monomer,
producing a so-called domain-swapped dimer. This domain swapping phenomenon is
characterized in detail in chapter 3.6.1.
Ligand-free Nck2-SH2
The molecular replacement of the ligand-free Nck2-SH2 structure was attempted us-
ing the SH2 domain of the Nck2-SH2/Tir8 complex (see below). EPMR did not yield
a convincing crystal packing as the molecules penetrated each other. The programs
AMORE (Navaza, 1994) and PHASER (Storoni et al., 2004) were employed instead,
but also did not yield convincing solutions. Sometimes, twinning of crystals is respon-
sible for not resolving a structure. Merohedral twinning is a phenomenon where the a-
and b-axes are exchanged in different regions of the crystal that may occur when a and
b axis are of the same lengths as in hexagonal crystals. The reflection pattern would
geometrically be unaltered but the reflection intensities would appear to have a higher
symmetry than the untwinned crystal. Merohedral twinning can be recognized by an-
alyzing the accentric moments of Ik/(I)k listed by the program TRUNCATE (French
& Wilson, 1978). The numbers of the Nck2-SH2 data set were heterogenous but did
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not reveal definite twinning. To increase the redundancy of the data set, the second
reflection pattern was also indexed and scaled onto the first data set. A reasonable
crystal packing, however, could still not be generated. As this data set did not yield a
structure solution and no other suitable crystals were available during this study, the
crystal structure of ligand-free Nck2-SH2 could not be obtained.
Nck1-SH2/Tir12
The structure of Nck1-SH2/Tir12 was solved using EPMR with the ligand-free, canon-
ical Nck1-SH2 domain as model. The correlation coefficient was 40% indicating a cor-
rect model, the R-factor, however, rather high with 58%, but the crystal packing was
reasonable and thus the structure taken for refinement. The structure refinement was
directly started in REFMAC5 with a rigid body refinement followed by restrained and
tls-refinement. Between refinement cycles, the protein model was manually adjusted to
the electron density. Already in the first manual refinement cycle before the peptide had
been modelled, positive difference electron density was visible in the phosphotyrosine
binding pocket and in the adjoining regions indicating that the peptide was present
in the crystal. The peptide was built into the positive electron density and refined
along with the remaining structure (Fig. 3.20). Electron density was clearly visible for
all amino acids except Glu-4 and -3 at the N-terminus of the phosphopeptide, and
the side chain of Glu+2. Due to high resolution data, atoms could be placed into the
electron density with high accuracy. Amino acids 324-326, 335-338, 350-351 and 363-
368 corresponding to loop regions, however, were partly disordered, and several loop
conformations were modelled.
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Figure 3.20: Stereographical view of the electron density of the Tir12 phospho-
peptide complexed to Nck1-SH2. (A) Electron density calculated using exclusively Nck1-
SH2 (ribbon diagram, blue) without peptide. Positive difference electron density (green mesh)
clearly indicates the missing Tir phosphopeptide. (B) Electron density calculated using Nck1-
SH2 complexed to Tir12. Tir12 (ball-and-stick) smoothly fits into the 2FoFc density (blue
mesh).
Nck2-SH2/Tir8
The structure of Nck2-SH2 in complex with Tir8 was solved using the structure of
Nck1-SH2/Tir12 without peptide. The best solution identified by EPMR resulted in
a rather high R-factor of 57%, but a correlation factor of 31% indicating a suitable
solution, and crystal packing was physically reasonable. 18 cycles of geometrically re-
strained refinement (plus tls-refinement in the last cycles) alternating with one round
of manual rebuilding were sufficient to optimally adapt the protein to the electron
density. As for the Nck1-SH2/Tir12 structure, positive difference electron density was
visible in the phosphotyrosine binding pocket and the adjoining groove of Nck2-SH2
before the peptide was added to the model. In ten side chains, residual difference den-
sity necessitated alternative side chain conformations to be modelled. The loops were
more rigid than in the Nck1-SH2/Tir12 complex and not delocalized.
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Refinement statistics for all structures are summarized in Table 3.7.
Table 3.7: Structure refinement.
Nck1-SH2 Nck1-SH2/Tir12 Nck2-SH2/Tir8
Resolution range A˚ 30.3 - 1.8 28.0 - 1.5 20.0 - 1.45
R [%] 21.7 19.8 14.9
Rfree [%] 24.0 23.8 17.5
No. of reflections 10457 28813 16143
working set 9931 27281 15264
test set 526 1532 879
Water molecules 65 246 117
Side chains
in multiple conformations 13 43 10
Overall B factor [A˚2] 26.0 10.7 15.3
Rms bond lengths [A˚] 0.033 0.021 0.025
Rms bond angles [°] 2.62 1.96 1.93
3.5.3 Conformation of structures
Apart from crystallographic and free R-factors, the stereochemistry of the backbone is
important to assess the quality of a crystal structure. The conformation of the main
chain is generally checked by a Ramachandran plot, that plots the dihedral angles φ and
ψ of each amino acid against each other. Residues should cluster within energetically
favored regions.
As an example, the Ramachandran plot of Nck1-SH2/Tir is shown here (Fig. 3.21). A
large majority of residues are located in allowed regions. Four residues have unusual
backbone conformations. Two of them are part of the phosphopeptide: the glutamate
(Glu0(M)) is at the N-terminus of the peptide, and the aspartate (Asp9(M)) forms a
salt bridge with an asparagine in the SH2 domain. The other amino acids (Glu55(A),
Glu84(A)) are located in loop regions in Nck1-SH2. The results of the plots for each
structure are summarized in Table 3.8.
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Figure 3.21: Ramachandran plot of Nck1-SH2/Tir12. The red area corresponds to
energetically favoured regions, main chain atoms in dark yellow parts are sterically allowed.
Light yellow and white regions are classified as “generally allowed” and “prohibited”, respec-
tively. Glycines are represented by triangles. Amino acids with unfavourable dihedral angles
are named explicitly. The plot was generated using PROCHECK (Laskowski et al., 1993).
Table 3.8: Ramachandran plot summary.
Nck1-SH2 Nck1-SH2/Tir12 Nck2-SH2/Tir8
Residues in
most favoured regions [%] 92.0 87.4 94.8
additionally allowed regions [%] 8.0 10.6 5.2
generously allowed regions [%] 0.0 1.0 0.0
disallowed regions [%] 0.0 1.0 0.0
3.6 Structure analysis
3.6.1 Domain swapping in the unliganded Nck1 SH2 domain
The SH2 domain of Nck1 is essentially composed of a central β-sheet (βB/C/D) flanked
by two α-helices (αA/B), forming the core of the protein (Fig. 3.22). In addition to the
central β-sheet, Nck1-SH2 exhibits a second β-sheet (βF’/F”) protruding beyond the
central plane.
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Figure 3.22: The ligand-free Nck1 SH2 domain. Ribbon diagram of the monomeric,
canonical Nck1-SH2 structure. The molecular surface is shown in transparent blue.
Unexpectedly, the Nck1 SH2 domain forms domain-swapped dimers in the crystal
rather than the anticipated monomers (Fig. 3.23).
Figure 3.23: Domain swapping in the ligand-free Nck1-SH2 dimer. The monomeric
units are coloured in blue and orange. The strand exchange takes place after residue 336 in
loop D’E (GluD’E1). Instead of folding back and forming a β-sheet, the β-strand E elongates
the β-strand D’. Consequently, the structure opens up and the hydrophobic core is exposed.
A second monomer interacts with this hydrophobic interface, and so a dimer is formed. A
model of Tir12 (grey, ball-and-stick) binding to the domain swapped Nck1-SH2 dimer shows
that peptide binding still would be possible while the peptide orientations were antiparallel.
In each domain, the loop connecting β-strands D’ and E adopts an extended confor-
mation spatially separating the N- and C-terminal halves of the domain. Two such
extended monomers in anti-parallel orientation create an elongated dumbbell shaped
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dimer fused by their complementary hydrophobic cores. Modeling a peptide ligand
onto the SH2 domains indicates that peptide ligand binding should be undisturbed by
the domain swapping (Fig. 3.23). If the dimer swapped domains bound phosphopep-
tides simultaneously, the distance between both phosphotyrosines (Cα-atoms) would
be ∼ 42 A˚. As shown in Fig. 3.23, the orientation of the peptides in the dimer would be
perpendicular to that of the exchanged β-sheet with opposed chain direction. A single
peptide bearing two phosphotyrosines would hence need to bend through ∼ 180 ° to
occupy both binding sites. Thus, either doubly phosphorylated peptides with tyrosines
separated by ∼ 25 or more residues, or two binding sites in separate molecules would
be able to occupy the peptide binding grooves in dimerized SH2 domains.
To establish whether the crystallographically observed dimers might be physiologically
relevant, the oligomerization state of Nck1-SH2 in solution was to be analyzed. An-
alytical gelfiltration and dynamic light scattering as shown in chapter 3.2.2 already
indicated that Nck1-SH2 is monomeric in solution. To confirm this also for concentra-
tions comparable to those in the crystallization setups, equilibrium ultracentrifugation
experiments were performed in cooperation with Prof. Claus Urbanke, Medizinische
Hochschule Hannover (Table 3.9). However, even at 3.1 mg/mL Nck1-SH2 oligomers
were not detected. Thus, the observed domain swapping is likely to be a crystallo-
graphic artifact.
Table 3.9: Comparison of theoretical molecular mass and mass determined by
ultracentrifugation.Mtheo – theoretical mass, MUC –mass according to ultracentrifugation.
Concentration [mg/mL] Mtheo [Da] MUC [Da] oligomerization
Nck1-SH2 0.2 11730 11970 monomeric
0.5 11730 10780 monomeric
3.1 11730 11040 monomeric
3.6.2 Interactions between Nck SH2 domains and phospho-
peptides
To analyze the interaction of Nck and Tir in atomic detail, we solved and refined
the crystal structures of the Nck1-SH2 and Nck2-SH2 domains complexed with Tir-
derived phosphopeptides at high resolution of 1.50 A˚ and 1.45 A˚, respectively (Fig.
3.24). Domain swapping was not observed in either complex structure.
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Figure 3.24: Structures of Nck1-SH2 and Nck2-SH2 complexed to Tir-derived
peptides. Left: Nck1-SH2 complexed to Tir12 (yellow); Right: Nck2-SH2 complexed to Tir8
(green); red/blue/pink sticks – oxygen, nitrogen, phosphorus atoms. Colours of the protein
surface indicate the electrostatic potential: blue – positively charged, red – negatively charged,
white – neutral. The electrostatic surface presentations of both Nck SH2 domains display
the deep, positively charged pocket (blue) that is bound by the phosphotyrosine of the Tir
peptides.
Amino acids involved in phosphopeptide recognition and binding are invariantly con-
served between Nck1-SH2 and Nck2-SH2. As a result, the interactions between Nck1-
SH2 and Tir12 summarized in Figure 3.26, hold for Nck2-SH2/Tir8 as well with the
exception of a single hydrogen bond between SerBC2-N and the phosphate group of the
peptide that is not present in Nck2-SH2/Tir8. As observed in other SH2 domains, the
phosphate group of the tyrosine is tightly bound in a hydrophilic, positively charged
pocket (Fig. 3.25).
CHAPTER 3. RESULTS 72
Figure 3.25: Stereo graphical view of the phosphotyrosine binding pocket of Nck1-
SH2. Blue mesh – electron density; orange – phosphotyrosine of Tir12; grey –Nck1-SH2; red –
oxygen atoms; blue – nitrogen atoms; pink – phosphorus atom; green dotted lines – hydrogen
bonds.
Two conserved arginines (ArgαA2 and ArgβB5) coordinate the phosphate group to-
gether with three serines (SerBC2, SerβB7 and SerβC3) and the backbone of a gluta-
mate (GluBC1). ArgαA2 forms a partly bifurcated salt bridge to a phophate oxygen. It
also participates in an amino-aromatic interaction (cation-pi interaction) with the phe-
nol ring of the phosphotyrosine and forms a hydrogen bond to Ile-1-O. LysβD6 interacts
hydrophobically with the phenol ring. The specificity of the interaction between the Tir
phosphopeptide and Nck is mediated through several additional flanking residues and
relies on hydrophobic interactions, as well as hydrogen bonds and salt-bridge interac-
tions. Most importantly Val+31, located in a Src-typical hydrophobic pocket (Waksman
et al., 1993), allows the peptide to bind in an extended conformation. The hydropho-
bic pocket embedding Val+3 is formed by four residues, PheβD5, IleβE4, TyrαB9 and
IleBF’2. The side chain of the charged Asp+1 forms a hydrogen bond to HisβD4-N and
an indirect interaction to LysβD6 mediated by a water molecule. The Asp+1 backbone
nitrogen forms a second hydrogen bond with the HisβD4-O. Recognition of Ala+4 is
achieved through hydrophobic interactions with PheβF’1 and IleBF’2, and a hydrogen
bond between IleBF’2 and the Ala+4-N. Ile-1, immediately N-terminal of the phos-
photyrosine, hydrogen bonds ArgαA2 through its backbone amide. The side chain of
His-2 coordinates in one conformation the tyrosine phosphate group intramolecularly,
and hydrogen bonds the side chain of GluBC1 in the other conformation. The 12 amino
acid phosphopeptide in the Nck1-SH2/Tir12 complex shows an additional interaction:
Asp+6 forms a salt bridge with ArgβF1.
1Amino acid positions in SH2 domain binding peptides are labelled according to the phosphotyro-
sine, e.g. Val+3 is a valine three residues C-terminal of the phosphotyrosine.
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Interactions for Nck1-SH2 and Nck2-SH2 are listed in detail in the appendix.
Figure 3.26: Interactions of Nck1-SH2 with Tir12. Black bonds –Tir12; yellow
bonds –Nck1-SH2; black/blue/red/pink balls – carbon/nitrogen/oxygen/phosphorus atoms;
black dotted lines – hydrophilic interactions; turquoise archs – hydrophobic interactions; blue
dashed line – cation-pi interaction. The plot was modified according to a ligplot (Wallace et al.,
1995).
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3.6.3 Comparison of Nck1-SH2 and Nck2-SH2 complex struc-
tures
Overall the complexed SH2-domains are structurally quite similar to their ligand-free
counterpart. The rms deviation for common Cα atoms is 0.90 A˚ for Nck1-SH2/Tir12
compared to the ligand-free structure, and 0.85 A˚ for Nck2-SH2/Tir8. Superimposing
the peptide complexes of Nck1-SH2 and Nck2-SH2, indicates that the complexes too
are very similar (Fig. 3.27).
Figure 3.27: Superposition of Nck1-SH2/Tir12 and Nck2-SH2/Tir8. Yellow –
Nck1-SH2/Tir12; green –Nck2-SH2/Tir8; black/blue/red/pink sticks – carbon/nitrogen/-
oxygen/phosphorus atoms of side chains.
The rms deviation for common Cα-atoms of the SH2 domains is 0.73 A˚. Differences in
the structure are essentially confined to the loop regions. This is also the region bearing
most non-conserved residues between Nck1 and Nck2 SH2 domains. An analysis of the
variable amino acids in the structures shows that the area of the binding interfaces to
the phosphopeptides does not bear any of the mutations (Fig. 3.28).
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Figure 3.28: Amino acid exchanges of Nck1-SH2 versus Nck2-SH2. (A) Structure
based sequence alignment of Nck1-SH2 and Nck2-SH2. Residues in green boxes are involved
in Tir12 phosphopeptide binding. Filled red boxes indicate identical amino acids, red prints
homologous residues. Secondary structure of both Nck SH2 domains is indicated as arrows
(β-strands) and helices (α-helices). Numbers above amino acids correspond to the sequence
position in Nck1. (B) Structure superposition. Exchanged amino acids are shown as stick
model. Yellow –Nck1-SH2; green –Nck2-SH2; grey –Tir phosphopeptide; red – oxygen atoms
of side chains; blue – nitrogen atoms of side chains. The peptide interaction surface is com-
pletely conserved.
3.7 Mapping the binding preferences of Nck SH2
domains to tyrosine phosphorylated peptides
The exact binding preferences of Nck1-SH2 and Nck2-SH2 to phosphopeptides were
determined using an epitope scan. We performed the epitope scan based on single
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amino acid replacements of the high-affinity binding Tir12 sequence. 201 separate 12-
residue phosphopeptides were analyzed, replacing each amino acid of Tir12 in turn
by all genetically encoded L-amino acids (cysteine was chemically protected by an ac-
etamidomethyl group). Figure 3.29 depicts the binding of Nck1-SH2 to the individual
peptides (one spot represents one peptide), darker colors indicate tighter binding. Vari-
ation of the first position of the Tir12 phosphopeptide, Glu-4, is shown in the top row,
starting at the left-hand corner and replacing this residue by all 20 amino acids. The
sequence alphabetically follows the single letter code. Note that the original amino acid
is included, such that the fourth spot (Glu-4 replaced by glutamate) may be taken to
represent a positive control. All twelve such spots are marked by red boxes. Negative
controls (lacking the phosphate group on the tyrosine) are marked as black boxes.
Figure 3.29: Example of an epitope analysis using an array of peptides spotted
onto a cellulose membrane. Each spot position corresponds to a single replacement ana-
logue (tyrosine excluded) of the 12 amino acid Tir peptide. Variation of the first position,
Glu-4, is shown in the top row, starting at the left-hand corner (position A/1) and replac-
ing this residue by all 20 amino acids (positions A/1 to A/21). The sequence alphabetically
follows the single letter code i.e. A-alanine, C-cysteine, D-aspartate, E-glutamate etc. Posi-
tion A/22 to B/17 corresponds to mutation of Glu-3 and so forth. Dark spots correspond to
tightly binding peptides.
The results from three such experiments were averaged and rearranged to group amino
acids according to their properties (Fig. 3.30). Positive controls are again marked by
red boxes, while negative controls are excluded as they all displayed no binding, as
expected. Positive controls are additionally grouped below the table to reflect the in-
herent variability of the experiment. The standard errors of the mean (SEM) for all
peptides were averaged for each position and are shown below each column. Numbers
used to generate the figure and SEM for each peptide position are listed in the appendix
(see appendix B). The epitope scan clearly confirms the critical importance of phos-
photyrosine and Val+3, as inferred from the Nck/phosphopeptide crystal structures.
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Figure 3.30: Normalized representation of binding data for Nck1-SH2 and Nck2-
SH2. Each box represents one peptide. The peptide sequence derives from the Tir12 sequence
(topmost line) mutated at the corresponding position with a genetically encoded amino acid
according to the column position. As an exception, the phosphorylated tyrosine (green col-
umn) was not exchanged as the phosphotyrosine is essential for peptide binding. Cysteine is
excluded from evaluation as it was chemically protected by an acetamidomethyl group. Dark
shades of blue indicate tight binding of the peptide to Nck-SH2, a white shading implies no
binding. SEM values averaged from all replacement analogues of one peptide position (below
each column) and the line of control peptides (Tir12 peptides) below the table gives an im-
pression of the variability of the data. The near absolute requirement of residues Asp+1 and
Val+3 for Nck1-SH2 and Nck2-SH2 binding is striking.
Listing the residues by the degree of importance yields the following:
pTyr: Lack of the phosphate group completely abolishes peptide binding (green boxes
in Fig. 3.30).
Val+3: Replacement of Val+3 by proline still allows some binding in Nck1, but less
in Nck2. Essentially no other amino acids are tolerated at this position.
Asp+1: Only substitution by glutamate (Nck1/2), serine and threonine (Nck1) main-
tain residual binding. Interestingly, glutamate is severely discriminated against the +1
position.
Asp+6: Bound by ArgβF1 via a salt bridge in the crystal structure, Asp+6, can be
replaced by glutamate presumably by restoring a similar ionic interaction to ArgβF1.
Most other amino acids result in some residual binding affinity, whereas positively
charged amino acids arginine and lysine completely abolish peptide-binding. Large
hydrophobic residues also are unfavorable.
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Ala+4: Though slightly larger, threonine and serine may replace alanine at position
+4. Presumably the terminal methyl group of threonine, and to a lesser extent the
methylene group of serine, is able to fill the hydrophobic pocket that accommodates
Ala+4 in the crystal structure. Additionally, serine and threonine can form hydrogen
bonds to the backbone carbonyl oxygen of ProBF’1 that should further stabilize the
interaction. Interestingly, tyrosine can also occupy the +4 position resulting in a binding
affinity comparable to alanine, serine and threonine, possibly through stacking with
PheβF’1. Only few amino acids abrogate binding to Nck1-SH2 completely, including
tryptophane, arginine and lysine whereas Nck2-SH2 tolerates less amino acids.
His-2: His-2 that structurally appears to have the function of completing the phospho-
tyrosine binding pocket, may be replaced by small hydrophobic residues such as alanine,
proline and valine. Most other amino acids still allow residual binding, Nck1-SH2 again
tolerating more amino acids than Nck2-SH2.
Ile-1: Despite Ile-1 being in contact with the SH2 domain via its backbone only, large
hydrophobic amino acids are preferred at this position. However, most amino acids do
not diminish binding severely except tryptophane, asparagine (Nck1/2), proline and
glycine (Nck2).
Glu+2: Although Glu+2 does not interact with the SH2 domains through its side chain
in the crystal structures, it cannot be replaced by every amino acid. Most exchanges in-
duce lower binding affinity though only aromatic amino acids and, interestingly, glycine
lead to a complete loss of affinity.
Glu-4/Glu-3/Ala+5/Pro+7: The residues at the N- and C-terminus of the pep-
tide and Ala+5 are significantly less restrained towards amino acid replacements. The
N-terminal glutamates as well as Ala+5 are essentially freely exchangeable. Pro+7,
however, may not be replaced by tryptophane or positively charged amino acids with-
out a severe affinity loss to Nck2-SH2.
Comparing the averaged peptide scans of Nck1-SH2 and Nck2-SH2 indicates that both
proteins have very similar binding preferences. The SH2 domain of Nck2 seems to be
more sensitive towards mutations with the result that more mutations cause a complete
loss of a detectable binding signal. That is in line with the observation that Nck2-SH2
binds weaker to phosphopeptides in the SPR experiments. As a certain binding affinity
has to be exceeded to output a detectable binding signal in the epitope scan, less
peptides reach this affinity when binding to Nck2-SH2 in comparison to Nck1-SH2,
and thus more mutations result in abrogation of Nck2-SH2 binding in the epitope
scan.
Beside determining binding preferences for both SH2 domains, the epitope scan was
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also used to confirm the SPR experiments. All phosphopeptides analyzed by SPR
spectroscopy were additionally spotted onto the epitope scan membrane at positions
J9-15 (EphrinB1, ephrinB2, PDGFR-Y751, PDGFR-Y1009,Dab-1-Y220, Dab-1-Y232,
A36R, respectively). None of these phosphopeptides bound detectably to Nck1-SH2 or
Nck2-SH2 in any of the epitope scans (see epitope scan membrane in Fig. 3.29 as exam-
ple). That was expected for both Dab-1-derived phosphopeptides and for one PDGFR-
derived phosphopeptide (binding site Y751), as all three did not bind in SPR ex-
periments. The other three phosphopeptides (A36R, PDGFR-Y1009 and ephrinB1/2)
showed a binding constant around 10 µM and 100 µM to Nck1-SH2 and Nck2-SH2,
respectively, in SPR experiments, thus three orders of magnitude weaker than Tir. As
these three phosphopeptides did also not interact with both Nck SH2 domains in the
epitope scan, all phosphopeptides detected in the epitope scan consequently have to
bind tighter than 10 µM. Thus, the epitope scan confirms that the Tir-derived phos-
phopeptide binds significantly tighter to both Nck SH2 domains than all other peptides
tested in SPR experiments.
3.8 GIT1 is a potential interaction partner of Nck
3.8.1 TrEMBL database search based on the epitope scan
The amino acid preferences revealed by the epitope scan allow new potential interaction
partners to be identified in protein sequence databases such as TrEMBL. The service
PepPat (Jiang et al., 2003) was used to search for the sequence X-X-X-X-Y-D-X-V-
[A/Y/S/T]-X-[D/E/C]-X where X means that this position can be occupied by any
amino acid. 52 hits in the TrEMBL database were obtained of which four proteins
particularly closely match the search pattern and are tyrosine phosphorylated proteins
involved in cytoskeleton dynamics (Fig. 3.31).
Figure 3.31: Binding sites of potential interacting partners of Nck SH2 domains.
Dark green – positions restricted to one type of amino acid; light green – positions restricted to
a number of amino acids; no color – any amino acid allowed. Right column – sequence position
of the potential phosphotyrosine.
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3.8.2 Nck associates with tyrosine phosphorylated GIT1
To prove that phosphoproteins bearing a corresponding Nck binding motif such as
GIT1 can in principle associate with Nck1 and Nck2 SH2 domains, pull-down assays
were performed in cooperation with Theresia E.B. Stradal, Cell Biology, GBF. GIT1
was shown to be tyrosine phosphorylated after phorbole ester treatment of cells, and
to localize (and potentially colocalize) with Nck in focal adhesions (Zhao et al., 2000),
and was thus selected as first choice for this set of experiments. A431 human skin
carcinoma cells and HeLa human cervix carcinoma cells were used due to expression
of endogenous GIT1 and either starved for 24 hours to bring down phosphorylation to
basal levels or starved and then stimulated with full medium containing phorbole ester
to induce hyper-phosphorylation. The SH2 domains of both Nck1 and Nck2 were able
to precipitate endogenous GIT1 from lysates of stimulated but not starved cells (Fig.
3.32), indicating that phorbole ester treatment indeed induces phosphorylation of the
motif around Tyr383 and that GIT1 in this form can associate to the recombinant SH2
domains of both Nck family members.
Figure 3.32: Pull-down of GIT1 through Nck1 and Nck2 SH2 domains. Glutathione
sepharose coupled GST fused to Grb2-SH2, Nck1-SH2 or Nck2-SH2 was incubated with either
starved or stimulated cells containing endogenous GIT1 (lysate). GST alone was used as
control. WB GIT1 –western blot using α-GIT1 antibody. Staining of the lower edge of the
Nck1-SH2 lane is due to cross-reactions of the α-GIT1 antibody.
Hence, these findings support the virtual identity of the binding specificities of Nck1
and Nck2 SH2 domains and substantiate that the determined consensus motif for these
domains is useful to identify potential interaction partners of Nck proteins.
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Chapter 4
Discussion
4.1 Domain swapping in the unliganded Nck1 SH2
domain
A variety of proteins has been observed to form oligomers through interchanging parts
of their structure – a phenomenon called “domain swapping” (for review see Rousseau
et al. (2003)). Dimerization through domain swapping has been reported in several
tens of cases but higher oligomers also are feasible (Fig. 4.1). The biological func-
tion of domain swapping has been proposed as mechanism for regulating functions,
as evolutionary strategy for creating protein complexes and as mechanism for protein
aggregation (Bennett et al., 1994, 1995). Glyoxylase I from Pseudomonas for example
occurs both as monomer and domain swapped dimer in solution (Saint-Jean et al.,
1998). Remarkably, the active dimer can be reverted to the metastable, less active
monomer through the addition of glutathione and slow removal of glutathione restores
the domain swapped protein, indicating that domain swapping may be used to regulate
function. An intriguing physiological function has been proposed for multimerization
through domain swapping in context of prion processes and amyloid formation, both
linked to severe neurodegenerative diseases (Klafki et al., 1993; Cohen & Prusiner,
1998; Sinha et al., 2001).
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Figure 4.1: Principles of domain swapping. (A) Monomeric proteins can form (B)
dimers through domain swapping or (C) oligomers (here shown as open-ended form). Modified
according to Rousseau et al. (2003).
The ligand-free Nck1-SH2 is not the first SH2 domain that shows domain swapping.
Two crystal structures of the SH2 domain of the related adapter protein Grb2, unli-
ganded as well as complexed to a peptide, were found to exist as strand exchanged
dimer (Schiering et al., 2000; Nioche et al., 2002). Whereas it is the β-strand βD’ that
is extended in Nck1-SH2, the EF loop is the site of exchange in both Grb2 structures.
In solution, 80% of the complex of phosphopeptide-bound Grb2 is dimeric (Schiering
et al., 2000). In this study however, Nck1-SH2 could not be shown to exist as a dimer
in solution. Even at concentrations comparable to that employed for crystallization, no
dimeric Nck1-SH2 proportion could be detected. Furthermore, the crystal structure of
Nck1-SH2 in complex with the Tir-derived phosphopeptide also did not show domain
swapping. Possibly, the chaotrope guanidinium hydrochloride, present in the crystal-
lization solution of ligand-free Nck1-SH2, may have induced the partial unfolding of
the protein domain, facilitating dimer formation by domain swapping. Favoured ther-
modynamically, the dimer may have accumulated sufficiently to form the constituent
of the ensuing crystals. Thus, the results from this study do not indicate a potential
physiological role for domain swapping in vivo.
4.2 Nck SH2 domains compared to other SH2 do-
mains
In 1991 SH2 domains were found to function as phosphotyrosine recognition module
(Koch et al., 1991). Since then a range of SH2 domains in complex with specific binding
sites have been crystallographically analyzed. A superposition of several structures (Fig.
4.2) reveals that the domain structure, a central β-sheet flanked by two α-helices, is
highly conserved.
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Figure 4.2: Superposition of SH2 domains. Nck2-SH2 (black) is superimposed with
crystal structures of Src- (pink), Lck- (green), Syp- (yellow) and Grb2-SH2 (blue). An addi-
tional β-sheet is formed in the loop connecting α-helix A and β-strand G of Nck1 and Nck2
(red circle).
The loop regions are less well conserved than the central domain structure. The BG-
loop, connecting α-helix B and β-strand G of Nck SH2 domains, deviates structurally
from other SH2 domains in that it exhibits an additional β-sheet. The β-strands com-
prise three residues each and are named βF’ and βF” (Fig. 4.3). Most SH2 domains
contain fewer residues in this loop region, Syp however comprises no β-sheet although
containing as many residues as Nck.
Figure 4.3: Structure based sequence alignment of SH2 domains. Secondary struc-
ture found in all SH2 domains is colored in black. β-strands creating an unconserved sheet
are colored in red. Red boxes indicate identical amino acids, red prints homologous residues.
Numbers above amino acids correspond to the sequence position in Nck1.
Recently, Ran & Song (2005) presented the solution structure of the Nck2 SH2 domain
confirming the additional β-sheet. This is therefore not a consequence of crystal pack-
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ing effects. Our crystal structures show that the β-sheet is present in the ligand-free
Nck1 SH2 domain as well as in the complex structures. It is thus a unique structural
feature of the Nck family. As it is located on the same side like the phosphopeptide
binding site it could possibly interact with other parts of the phosphoprotein target,
and thus influence the SH2 – phosphoprotein interaction. An interesting example of an
unusual SH2 interaction through a β-sheet was identified in the crystal structure of
full-length SHP-2 phosphatase (Hof et al., 1998). The phosphatase was found to in-
hibit itself by blocking its phosphatase active site by a section of the N-terminal SH2
domain (the D’E-loop, βD and βE strands). Thus, other parts of SH2 domains than
the phosphopeptide binding site indeed may play a role for in vivo function and may
serve to discriminate the Nck SH2 domains from others.
4.2.1 Comparison with the Src SH2 domain
The SH2 domain of Src was the first one described structurally (Waksman et al., 1992).
Nck1 was assigned to the Src-like SH2 domains by Songyang et al. (1993). However,
Nck1 does not prefer the phosphopeptide sequence pY-E-E-I like most SH2 domains of
the Src kinase family, but binds pY-D-E-V preferentially (Songyang et al. (1993) and
this work). The crystal structures of Nck1 and Nck2 SH2 domains in complex with the
high-affinity Tir peptide now allow to explain the binding differences of Src and Nck
in atomic detail. A structure based sequence comparison of Nck1-SH2, Nck2-SH2 and
Src is shown in Fig. 4.4. Residues in green boxes are predominantly responsible for
differences in binding specificities.
Figure 4.4: Structure based sequence alignment of Nck and Src SH2 domains.
Residues in green boxes are predominantly responsible for differences in binding specificities.
Secondary structure of Nck-SH2 is indicated as arrows (β-strands) and helices (α-helices). β-
strands creating an unconserved sheet are colored in red (see chapter 4.2). Red boxes indicate
identical amino acids, red prints homologous residues. Numbers above amino acids correspond
to the sequence position in Nck1. The annotation of residues is shown below the alignment.
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Figure 4.5: Superposition of binding pockets of Src and Nck1 SH2 domains. Or-
ange – Src binding phosphopeptide; green –Nck binding phosphopeptide; yellow – Src residues;
light yellow – Src backbone; blue –Nck residues; light blue –Nck backbone. (A) Electrostatic
interactions in the peptide – SH2 domain complexes. Glu+2 forms a salt bridge with ArgβD’1
in the Src – phosphopeptide complex that is not present in the Nck – phosphopeptide com-
plex as residue βD’1 in Nck is a glutamine. (B) Hydrophobic pocket. Ile+3 of the Src binding
phosphopeptide is slightly pulled out of the pocket relative to Val+3 of the Nck binding phos-
phopeptide, due to the Glu+2 salt bridge and the smaller hydrophobic pocket (threonine in
Src-SH2 instead of glycine in Nck1-SH2 at position EF1).
Superposition of the Src SH2 domain complexed to the high-affinity peptide pY-E-E-
I with both Nck complexes indicates that they are structurally similar with an rms
deviation (Cα-atoms) of 4.4 and 4.7 A˚ for Nck1-SH2 and Nck2-SH2, respectively. This
large value is predominantly due to differences in loop regions. The rms deviation for
the central β-sheet and its flanking α-helices by contrast only amounts to 0.66 and 0.61
A˚, respectively.
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The phosphotyrosine binding pocket of both complexes is essentially similar. The his-
tidine at position -2 in the Nck binding peptide, that structurally complements the
binding pocket of the phosphate, is not present in the Src binding peptide allowing the
phosphate to move 2.0 A˚ towards the ArgαA2 in Src. As a result, SerβB7 involved in
phosphate binding in the Nck structure is too far away for an interaction in Src. SerβC3
is exchanged for cysteine in Src, but superimposes well in binding the phosphate.
Differences in peptide binding are mediated through the residues C-terminally of the
phosphotyrosine (Fig. 4.5). Position +1 of the Src binding peptide is occupied by a glu-
tamate instead of an aspartate in the Nck complex. This aspartate is directly involved
in peptide protein recognition through an H-bond between the aspartate side chain
and the amide N of HisβD4. The corresponding glutamate side chain of the Src bind-
ing peptide is not involved in any interaction because LysβD3 to that it potentially
could form a salt-bridge contacts AsnβD1 of Src instead and is therefore not avail-
able to interact with Glu+1. Other Src – peptide complexes have, however, indicated a
LysβD3–Glu+1 interaction – there is thus some variability in this interaction.
Position +2 in both peptides is occupied by a glutamate. In the Nck complex, its side
chain is not involved in any contacts. In the Src complex, Glu+2 forms a salt bridge
to ArgβD’1. In Nck, this interaction is not possible as the arginine in positionβD’1 is
replaced by glutamine. As a result, the backbone (Cα-atom) of Glu+2 is shifted by 2.1
A˚ towards ArgβD’1 in the Src complex compared to Nck. This in turn significantly
affects the binding of the hydrophobic +3 residue.
The hydrophobic pocket for residue +3 is largely conserved in both structures. The
side chain of ThrEF1 in Src, however, is significantly bulkier than the corresponding
glycine in Nck partially obstructing the pocket compared to Nck. Due to the smaller
pocket, Ile+3 of the Src binding peptide is sterically prevented from entering the pocket
as deeply as Val+3 in the Nck complex. Although this decrease in hydrophobic contact
area could indicate an overall weakening of the interaction, it matches the shift due to
Glu+2 (described above) preventing excessive strain within the peptide.
Hence, the combination of a tight salt bridge to Glu+2 and a smaller hydrophobic
pocket significantly changes the overall interaction of Src relative to Nck allowing an
altered range of phosphoprotein targets.
4.2.2 Comparison with the Grb2 SH2 domain
Currently, Grb2 is the SH2/SH3 adapter protein characterized in most detail. Its pri-
mary biological function is to facilitate the activation of the small GTPase Ras in
response to receptor tyrosine kinase signalling through the recruitment of the guanine-
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nucleotide exchange factor (GEF) Son of sevenless (Sos) (Tari & Lopez-Berestein,
2001). The SH2 domain binds the phosphorylated EGF receptor while the SH3 do-
mains interact with Sos (Cohen et al., 1995). Grb2 has additional functions and often
colocalizes with Nck, e.g. in the actin recruitment complex of Vaccinia virus (Scaple-
horn et al., 2002) described in the introduction. Grb2 and Nck furthermore colocalize at
the surface of PIP2 induced vesicles known to be motile in an actin dependent manner
(Rozelle et al., 2000; Benesch et al., 2002). The Arp2/3 complex, N-WASP and WIP
are also recruited to the vesicle surface, creating an ensemble similar to the signalling
complex involved in vaccinia motility. The phosphopeptide binding mechanisms of Nck
and Grb2 however differ starkly, ensuring that distinct target sequences are recognized.
Figure 4.6: Superposition of Grb2 and Nck1 SH2 domains in complex with phos-
phopeptides. (A) Structure based sequence alignment of Nck and Grb2 SH2 domains.
Residue EF1 that closes the hydrophobic pocket of Grb2 is marked by a green box. Secondary
structure of Nck-SH2 is indicated as arrows (β-strands) and helices (α-helices). β-strands cre-
ating an unconserved sheet are colored in red (see chapter 4.2). Red boxes indicate identical
amino acids, red prints homologous residues. Numbers above amino acids correspond to the
sequence position in Nck1. The annotation of residues is shown below the alignment. (B)
Superposition of Nck1 and Grb2 SH2 domain structures. Blue –Tir peptide (dark) binding to
Nck1-SH2 (light). Orange –Phosphopeptide (dark) binding to Grb2-SH2 (light). Red –Grb2
residues responsible for β-turn conformation of the binding phosphopeptide. TrpEF1 occludes
the hydrophobic pocket hindering Val+3 to bind to Grb2. Asn+2 in consequence is able to
form hydrogen bonds to the backbone of Grb2 residue LysβD6.
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Comparing the crystal structures of Grb2 and Nck SH2 domains in complex with
corresponding peptides indicates that the phosphotyrosine binding pocket is completely
conserved resulting in a practically identical phosphotyrosine localization (Fig. 4.6).
Likewise, the N-terminal backbone atoms of the phosphopeptides superimpose very
well. As TrpEF1 in Grb2 fills the hydrophobic pocket, however, the C-terminal residues
of the peptide are forced loop back in stark contrast to the elongated binding mode
in Nck. Whereas Val+1 of the Grb2 bound peptide essentially occupies a comparable
position as Asp+1 in the Nck complex, the backbone thereafter folds back into a type
I β-turn conformation, allowing the functionally vital asparagine at position +2 to
interact with the backbone of LysβD6. The rest of the peptide points away from the
Grb2 domain while only Val+3 weakly interacts with the LysβD6 side chain through
hydrophobic contacts.
The different binding properties of Grb2 and Nck can thus largely be ascribed to
TrpEF1 in Grb2 that blocks the hydrophobic pocket observed in most SH2 domains. It
indeed has been shown for the Src SH2 domain that mutating the EF1 residue (Thr in
Src) into tryptophane switches the specificity of the Src SH2 domain to resemble that
of Grb2 (Marengere et al., 1994). The difference in specificity of Nck versus Grb2 is
physiologically relevant as Grb2 and Nck often colocalize and could potentially compete
for identical phosphoproteins.
4.3 Phosphopeptide binding specificities of the Nck
family
4.3.1 Binding specificities of Nck1 and Nck2 SH2 domains are
identical
This study originally initiated because of an inconsistency in literature concerning func-
tional differences of Nck1 versus Nck2. Although several experiments suggested identi-
cal phosphotyrosine target binding, others indicated significant differences in binding
specificity (see chapter 1.3.2). As these data derived from cell biological approaches,
biochemical quantification appeared most useful in resolving this inconsistency. This
has allowed the phosphopeptide binding specificities of Nck1 and Nck2 SH2 domains to
be characterized in detail for the first time by combining data from epitope scanning,
surface plasmon resonance (SPR) experiments and crystal structures of Nck1 and Nck2
SH2 domains.
Contrary to expectations from the literature, Nck1 and Nck2 SH2 domains were found
to exhibit largely the same binding specificities in SPR experiments. Phosphopeptides
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not binding to Nck1-SH2 similarly show no interaction with Nck2-SH2. Likewise, both
SH2 domains prefer the Tir-derived peptide as high-affinity partner whereas the bind-
ing affinity for A36R-, PDGFR-Y1009- and ephrinB1/2-derived phosphopeptides to
Nck1-SH2 and Nck2-SH2 is ∼ 1000 fold lower. The similarity in binding specificities
is confirmed by the epitope scan. Identical positions in the phosphopeptides are im-
portant for efficient binding of Nck1 and Nck2 SH2 domains, and both prefer largely
the same amino acids. The crystal structures explain this similarity as the interacting
amino acids are perfectly conserved in both complexes. Thus, the results of all three
methods clearly show that Nck1-SH2 and Nck2-SH2 exhibit identical phosphopeptide
binding specificities. The reported differences in cell biological behaviour, hence, can-
not be caused by differences in binding specificity of the binding sites examined in this
study.
Interestingly, despite identical binding specificities the SPR experiments indicate that
the binding affinities in absolute terms of Nck1 and Nck2 SH2 domains do differ. All
phosphopeptides that do bind were found to bind 2 to 9 fold more tightly to Nck1-SH2
compared to Nck2-SH2. This effect explains why Nck2-SH2 bound fewer peptides in
the epitope scan than did Nck1-SH2. The crystal structures however do not clarify this
phenomenon at an atomic level as all molecular interactions with the phosphopeptides
are identical in Nck1-SH2 and Nck2-SH2 complexes. The single exception is a hydrogen
bond between SerBC2-N and the phosphate group of the peptide that is not present in
the crystal structure of Nck2-SH2/Tir8 but formed in Nck1-SH2/Tir12. However, this is
due to a displacement of the loopBC of Nck2-SH2/Tir8 versus Nck1-SH2/Tir12 as result
of a different crystal contact. Residue BC5 is a glutamine in Nck1-SH2 but a serine
in Nck2-SH2, causing the loop displacement. Thus, it is questionable whether such an
effect may be responsible for weaker binding of Nck2-SH2 in solution experiments.
The cell biological effects of the observed affinity differences are not conceivable as other
factors like enlarged Nck-SH2 – phosphoprotein interaction surface in vivo compared to
phosphopeptide binding, multiprotein complex composition and cellular localization
may influence physiological Nck – target interactions significantly. A general trend of
Nck2 inducing less pronounced effects in cell biological experiments has not been ob-
served to date (T. Stradal, GBF, personal communication).
4.3.2 The Nck family binding motif
Songyang et al. (1993) estimated SH2 binding specificities by a seminal experiment
employing a phosphopeptide library that revealed a preference of Nck1 to the peptide
sequence pY-D-E-P/D/V (see chapter 1.4.1).
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The epitope scan performed here supports Asp+1 as being critical for the binding
affinity. The amino acid cannot be exchanged without a significant loss of affinity. The
crystal structures correspondingly indicate that the aspartate forms hydrogen bonds
to the Nck backbone. The longer side chain of glutamate would disturb this hydrogen
bond, explaining why glutamate cannot replace aspartate in this position as indicated
by the epitope scan.
Glu+2 is not observed to interact with the SH2 domain directly in the crystal structures
indicating that it may not be seen as critical residue. The epitope scan shows that
glutamate is preferred at that position, however, except for aromatic amino acids and
glycine most amino acids do not abrogate binding supporting the view that this position
is not very important for peptide binding.
The crystal structures of both Nck1-SH2 and Nck2-SH2 complexed to the Tir phos-
phopeptide indeed have a hydrophobic pocket closely embracing Val+3. The pocket
is too small to efficiently bind bulkier residues. This is corroborated by SPR exper-
iments where phosphopeptides exhibiting a methionine at position +3 did not bind
to Nck1-SH2 nor Nck2-SH2. Similarly, the epitope scan confirmed the preference for
valine. Apart from valine, proline was tolerated in the epitope scan but binding was
significantly weaker in contradiction to Songyang et al. (1993). While proline bound
weakly in the epitope scan, no binding at all could be observed for aspartate at position
+3, again contrasting the results of Songyang et al. (1993).
This study also clearly indicates that the central four amino acids of a phosphopeptide
do not exclusively dictate binding to Nck. Both His-2 and Ala+4 interact with Nck and
various amino acids are preferred at these positions in the epitope scan. The crystal
structure of Nck1-SH2/Tir12 revealed that Asp+6 forms a salt bridge to ArgβF1, and
the epitope scan confirms the importance of an interaction at that position for high-
affinity binding.
Thus, we can categorize the positions in the Tir12 phosphopeptide roughly into three
types: the essential residues, the preferred residues and the exchangeable residues.
Figure 4.7: Ranking of phosphopeptide positions. Dark green – indispensable phos-
photyrosine; green – essential residues; light green – preferred residues; no color – exchangeable
residues.
The experiments clearly revealed the important positions for high-affinity binding.
However, it has also become apparent that a single consensus sequence cannot be
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derived from the experiments. The epitope scan allows to estimate the preferred amino
acids for each position (Fig. 4.8).
Figure 4.8: Position dependent amino acid preferences of Nck1-SH2 as inferred
from the epitope scan. Amino acids are labelled according to one-letter-code. The relative
binding affinity of each single amino acid replacement analogue at each peptide position were
summed and defined as 100%. The height of each amino acid (proportional to its contribution)
thus represents the degree to which it is preferred at this position. Bars dominated by a single
or few symbols therefore represent discriminating peptide positions, while bars with many
symbols indicate positions of low discriminatory function.
The Tir-derived phosphopeptide emerged as the interaction partner of highest affinity
for both Nck1-SH2 and Nck2-SH2. A dissociation constant of roughly 0.1 µM as de-
termined for Tir in this study is common for high-affinity phosphopeptides binding to
SH2 domains (Bradshaw & Waksman, 2002). The potential physiological interaction
partners of Nck proteins however, exhibited a 500-fold weaker binding constant. As Tir
is a virulence factor it is reasonable for it to have a higher binding affinity, as it must
compete with the physiological targets for Nck. Interestingly, the affinity of the peptide
derived from the virulence factor A36R from Vaccinia virus is comparable to that of
the physiological phosphopeptides. It thus is clearly not necessary for the function of
a phosphoprotein to achieve high affinity for an SH2 domain exclusively through the
phosphopeptide sequence. However, as physiological partners of other SH2 domains
exhibit frequently a binding affinity of 100 nM to 1 µM (Ladbury et al., 1995), it seems
unlikely that such a weak interaction is able to transmit a cellular signal reliably.
This indicates that other factors may influence the SH2 – phosphoprotein interaction
in vivo and phosphopeptides in certain cases may not be sufficient to simulate the
SH2 – phosphotyrosine target interaction.
The affinity of an SH2 domain towards a target protein may potentially be enhanced
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through additional contacts outside the linear peptide sequences. No structures of SH2
domains in complex with true phosphoproteins could be solved to date, but several
unusual interactions of SH2 domains have been reported that show SH2 domains to
be able of forming interactions beyond classical peptide binding (Bradshaw & Waks-
man, 2002). For example the phosphotyrosine binding pocket of the N-terminal SH2
domain of the T-cell receptor binding protein Zap-70 is not exclusively formed by the
N-terminal SH2 domain, but involves residues of a second, C-terminal SH2 domain
of Zap-70 (Hatada et al., 1995). Additional interactions that could not be revealed
through experiments with phosphopeptides may raise the binding affinity of A36R and
other binding partners to Nck into a high-affinity range.
Another possibility for an SH2 domain to assure binding to its target despite low affinity
lies in the fact that signalling proteins often are part of multiprotein complexes. Other
proteins of the complex may assure localized enrichment of Nck near the potential
binding site and hence lower binding affinities may suffice for Nck to interact with its
target. In this context, serine, threonine and tyrosine phosphorylation of Nck itself (Li
et al. (1992) and T. Stradal, GBF, personal communication) may also be of importance
to recruit proteins that may be necessary for the ordered assembly of the required
multiprotein complex (see chapter 4.5.1).
4.4 Human binding partners of Nck1 and Nck2
4.4.1 Known interaction partners
Although interactions beyond the phosphopeptide binding site may support binding
in vivo, it is unlikely that these interactions can compensate for a non-binding phos-
phopeptide. Nck thus is unlikely to bind PDGFR at Tyr751 and to be an interaction
partner for Dab-1, as all three corresponding peptides did not interact with Nck in
SPR experiments.
Dab-1 is a tyrosine phosphorylated protein, required to transmit the Reelin signal that
regulates neuronal placement during brain development. Dab-1 has been identified to
interact with Nck2 but not Nck1 in a phosphotyrosine dependent manner by yeast-2-
hybrid, pull-down and co-immunoprecipitation experiments (Pramatarova et al., 2003).
However, Dab-1 was only detected in Nck2 immunoprecipitates whereas Nck2 was not
found in the reverse experiment using Dab-1 immunoprecipitates. This was interpre-
tated to indicate that only a small proportion of Nck2 interacts with Dab-1 under these
experimental conditions, possibly indicating that Nck2 may not be the physiological
interaction partner of Dab-1.
CHAPTER 4. DISCUSSION 93
Beside the phoshopeptides tested in SPR experiments, a variety of cellular binding
partners has been reported for Nck SH2 domains. Possibly, however, not all of these
interactions will turn out to be physiologically relevant. Do the binding specificities
determined as part of this work support these interaction partners?
The sequences of known interaction partner binding sites are listed in Figure 4.9,
revealing an unexpected heterogeneity.
Figure 4.9: Binding sites of reported binding partners. To analyze the peptide se-
quences for preferred or disadvantageous residues (according to the epitope scan), the average
binding signal of each peptide position in the Tir12 phosphopeptide was calculated (mean
of binding signals of all 20 amino acids tested) and set to 100%. Based on these values,
amino acids at each position can be classified as highly preferred residues (≥ 500%; dark
green boxes), advantageous residues (150-500%; light green boxes), average residues (50%
to 150%; no color), slightly disadvantageous residues (5% to 50%; light red boxes) and dis-
advantageous residues (no binding detectable; dark red boxes). Phosphopeptide name color
coding: green – binding in SPR experiments; red – no binding in SPR experiments; underlined
in green – likely to bind; underlined in red – unlikely to bind.
Phosphopeptides found not to bind Nck in SPR experiments contain at least one residue
that prevented peptide binding in the epitope scan. In addition these peptides contain
very few residues identified to be necessary for optimal binding and exclusively bear
a proline rather than valine at the key position +3. Phosphopeptides that were con-
firmed to bind in SPR experiments generally contain several advantageous residues,
in particular valine is invariantly found at position +3 and no residues classified as
disadvantageous. This agreement between SPR and epitope scan experiments suggests
predicting the binding behaviour of phosphopeptides not tested in SPR experiments.
Peptides listed that bear disadvantageous residues will presumably not bind to Nck
SH2 domains. Especially the phosphopeptide derived from EphB1 is very unlikely to
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interact with Nck as its sequence contains two residues that abrogated binding com-
pletely in the epitope scan. Likewise, FAK and Flt-1 (binding site around Y1213) will
presumably not bind Nck. They both have only few favorable residues and possess
average or disadvantageous amino acids at the key positions +1 and +3 of the peptide.
The remaining peptides Flt-1 (binding site Y1333), Dok1 and both SLP-76 binding
sites may bind to Nck, although as they all comprise proline instead of valine at po-
sition +3 and Dok1, moreover, a slightly disadvantageous residue at position +6, the
affinity is unlikely to be high.
4.4.2 GIT1 is a promising new interaction partner of Nck
Presently unidentified physiologically important phosphotyrosine targets of Nck1 and
Nck2 are likely to exist. They would presumably bear binding sites quite similar to that
of Tir. Using the motif Y-D-X-V-(A/Y/S/T)-X-(D/E/C) derived from the epitope scan
to search the TrEMBL database resulted in several potential interaction partners. Of
these proteins GIT1, GIT2, Nephrin and Ack1 are especially likely to be Nck interaction
partners. All are assumed to be tyrosine phosphorylated and have been implicated in
actin cytoskeletal dynamics.
Nephrin is the first component identified to be part of the slit diaphragm that forms the
critical and ultimate part of the glomerular ultrafiltration barrier (Kestila et al., 1998;
Ruotsalainen et al., 1999). It has been discovered to be a cell-cell adhesion molecule
of the Ig superfamily and is implicated in the actin cytoskeleton. The exact biological
role of Nephrin, however, is unclear.
Ack1 is a multidomain non-receptor tyrosine kinase. It is the only known tyrosine
kinase effector of Cdc42, a small GTPase of the Rho family that relays signals leading
to cell cytoskeleton rearrangements. Ack1 appears to interact with Nck through its
SH3 domains (Teo et al., 2001). This has, however, been challenged by analysis of the
Drosophila Nck and Ack homologues, Dock and DAck indicating that Dock interacts
with DAck exclusively via its SH2 domain (Worby et al., 2002). Thus, binding of the
human analogue Nck to Ack through its SH2 domain seems plausible.
The GIT (G protein-coupled receptor kinase-interactor) family of ADP-ribosylation
factor GTPase-activating proteins includes GIT1 and GIT2 (Vitale et al., 2000). GIT1,
studied in most detail, is believed to integrate signalling pathways responsible for vesicle
trafficking, adhesion and cytoskeletal organization. The multidomain protein provides
binding sites for ARF GTPases, paxillin and PIX, proteins involved in signal transduc-
tion of actin filament dynamics.
In this study, GIT1 was tested to investigate Nck binding and could indeed be shown in
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a pull-down assay to associate with Nck1 and Nck2 SH2 domains. The association was
dependent on phoshorylation of GIT1, and thus may potentially be mediated through
the predicted Nck binding site.
Is a GIT1 –Nck interaction physiologically feasible? In general, GIT1 is known to as-
sociate with PIX (PAK interacting exchange factor), a GEF (guanine-nucleotide ex-
change factor) (Premont et al., 2004), that is able to activate the small GTPase Rac
by exchanging GDP by GTP. When activated, Rac in turn activates “p21 activated
kinase” (PAK), a serine/threonine kinase, inducing actin cytoskeleton reorganization
and morphological changes.
Various studies have implicated Nck in PAK activation. Through its second SH3 domain
Nck interacts with a proline-rich motif on PAK (Bokoch et al., 1996; Galisteo et al.,
1996) and artificial membrane localization of this SH3 domain is able to activate PAK
(Lu et al., 1997). Interfering with the PAK–Nck interaction inhibits PAK-induced
membrane ruﬄing and focal complexes. A mutant of PAK that increases Nck binding
correspondingly emphasizes the Rac phenotype (Sells et al., 1997). Furthermore, PIX
may activate PAK kinase activity by association with PAK and Nck (Yoshii et al.,
1999).
Nck may thus activate PAK in response to tyrosine phosphorylation of GIT1. Inte-
grin/paxillin/focal adhesion kinase complexes induced by cell adhesion may recruit
GIT1 to focal adhesions via its paxillin binding site and phosphorylate the Nck bind-
ing site. Nck in turn may provide a scaffold to appropriately recruit and arrange PAK,
PIX and Rac and thus enable PAK activation (Fig. 4.10).
Figure 4.10: Potential role of Nck in Rac activation through GIT1, PIX and PAK
in focal adhesions. pY–phosphorylated tyrosine in GIT1; FAK– focal adhesion kinase.
GIT1 has furthermore recently been found to be recruited to newly forming synapses,
targeting PIX in turn and hence Rac, which is activated in the process and assumed
to be essential for actin remodelling required for formation of synapses (Zhang et al.,
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2003, 2005). As a result, Rac activates PAK that phosphorylates downstream targets,
resulting in dynamic rearrangements of the actin cytoskeleton. Mislocalization of GIT1
leads to alterations in spine morphogenesis and synapse formation. Interestingly, a
stretch of 32 amino acids of GIT1 was found to contribute significantly to efficient
synaptic targeting of GIT1. This stretch includes our newly predicted Nck binding site
in GIT1 (Y383) implicating Nck in targeting GIT1 to synapses.
Normally, Nck is recruited to the membrane by tyrosine phosphorylated receptors
through its SH2 domain and in turn recruits down-stream targets through the SH3
domains. Binding of GIT1 by Nck through the SH2 domain, would upset this mech-
anism. However, Nck could be recruited to the membrane through its SH3 domains.
For instance, the Netrin-1 receptor DCC (deleted in colorectal cancer) activates Rac1
in response to Netrin-binding. DCC has been shown to associate with Nck1 through
its SH3 domains potentially allowing its SH2 domain to bind an as yet unidentified
tyrosine phosphorylated protein that in turn recruits a guanine nucleotide exchange
factor protein for Rac1 to the site of Netrin activation (Li et al., 2002).
A similar mechanism may allow Nck to recruit GIT1 through its SH2 domain and
interact with a receptor via its SH3 domains (Fig. 4.11).
Figure 4.11: Potential role of Nck in GIT1 recruitment to synapses. Y383P –
phosphorylated Tyr383 of GIT1. Nck is coupled to a receptor via its SH3 domains and
recruits GIT1 upon tyrosine phosphorylation by its SH2 domain. This in turn leads to the
assembly of a PIX, PAK, Rac complex, resulting in actin remodelling and synapse formation.
Adapted according to Li et al. (2002).
4.5 Differences of Nck1-SH2 and Nck2-SH2
All experiments concurred that no differences regarding phosphopeptide binding speci-
ficity exist between Nck1-SH2 and Nck2-SH2. For the virulence factor Tir this was ex-
pected as it is known that both Nck1 and Nck2 can mediate pedestal building through
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the Tir –Nck interaction. In the case of the phosphopeptides of human origin, however,
this contradicts previous observations, e.g. ephrinB1 was reported to only interact with
Nck2 but not Nck1 (Cowan & Henkemeyer, 2001). How could the observed differences
in cell biological behaviour be reconciled?
EphrinB proteins are involved in cell-cell recognition e.g. in axon guidance and hind-
brain segmentation. An interaction of ephrinB with Nck2 was first identified through
yeast-2-hybrid screens and these were confirmed by pull-down and co-immunoprecipitation
experiments (Cowan & Henkemeyer, 2001). Nck1, by contrast was found not to interact
with ephrinB1 and its overexpression did not result in similar cellular responses caused
by overexpression of Nck2. The phosphopeptide of ephrinB1/2, in contrast, were found
in this study to bind both Nck1 and Nck2 SH2 domains.
The ephrinB1/2-derived phosphopeptide, however, did not bind with high affinity to
Nck SH2 domains. Possibly, an efficient in vivo response may require tighter binding
than provided exclusively through the phosphopeptide interaction (KD=20 µM). In
Nck2 additional interactions involving non-conserved amino acids may improve binding
and thus favor the Nck2 – ephrinB1 interaction. Furthermore, as Cowan & Henkemeyer
(2001) expressed the SH2 domains in stimulated eukaryotic cells, phosphorylation of the
Nck SH2 domains may affect complex formation with ephrinB1. Potential differences
between Nck1-SH2 and Nck2-SH2 phosphorylation are discussed below.
4.5.1 Posttranslational modifications
Apart from interactions involving non-conserved amino acids, differences in binding
may feasibly be mediated by posttranslational modifications. Nck is known to be ex-
tensively phosphorylated involving serine, threonine and tyrosine residues (Li et al.,
1992). The single SH2 domains of Nck1 and Nck2 also have been determined to be
tyrosine phosphorylated (T. Stradal, GBF, personal communication). A prediction of
phosphorylation sites using NetPhos (Blom et al., 1999), an artificial neural network
method trained with experimentally verified phosphorylation sites, yields distinct pat-
terns for Nck1 and Nck2 (Fig. 4.12).
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Figure 4.12: Posttranslational phosphorylation patterns of Nck1-SH2 and Nck2-
SH2. Each serine (blue), threonine (green) and tyrosine (red) residue in the Nck-SH2 se-
quences is assigned a NetPhos score. If the score sums up to more than the threshold the
amino acid is predicted to be phosphorylated. Tyrosine and serine phosphorylation sites that
are predicted in exclusively one of the Nck SH2 domains are labelled.
Most predicted phosphorylation sites of the SH2 domains are identical (4.12). However,
each protein comprises one potential serine (Nck1-S347, Nck2-S327) and one tyrosine
phosphorylation site (Nck1-Y339, Nck2-Y287) not conserved in the other SH2 domain.
Tyr339 of Nck1 is located in the strand βE and is thus inaccessible to kinases or
phosphotyrosine binding proteins. The tyrosine residue Tyr287 in Nck2 in contrast is
located in a solvent exposed loop and would indeed be accessible for kinases.
4.5.2 Phosphorylation of Tyr287 in Nck2 provides a Grb2-
SH2 binding site
An analysis of the Tyr287 surrounding sequence R-E-W-Y-pY-G-N-V-T-R-H-Q re-
veals the motif as Grb2-SH2 binding site as it bears an asparagine at position +2. This
suggests that an Nck2-SH2 –Grb2-SH2 complex may potentially form. As yet, an in-
teraction of an SH2 domain recognizing a second phosphorylated SH2 domain has not
been reported. The crystal structures of both Grb2 and Nck binding phosphopeptides
allow this potential complex to be modelled.
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Superimposing the phosphopeptide of the Grb2-SH2 complex onto the corresponding
region around Y287 of the Nck2 SH2 domain results in a surprisingly good match (Fig.
4.13).
Figure 4.13: Model of Grb2-SH2 binding Y287 of Nck2-SH2. (A) and (C): Super-
position of Grb2-SH2 (purple) with Nck2-SH2 (yellow) binding to Tir8 (grey). (B) and (D):
magnification of the superposition of the Grb2-SH2 binding phosphopeptide (purple) with
the loop around Y287 of Nck2-SH2 (yellow).
The Grb2-SH2 bound phosphopeptide superimposes particularly well with the residues
C-terminal to the phosphorylated tyrosine in the crystal structure of Nck2-SH2 with an
rms deviation (main chain atoms) for residues +1 to +4 of 0.91 A˚ (see Fig. 4.13 (B), up-
per left part). Tyr287 in Nck2-SH2 is bound hydrophobically to its surface, thus it has
to be turned upon phosphorylation to bind to Grb2-SH2. The amino acids N-terminal
of the phosphotyrosine (aromatic Trp and a second Tyr) are bound within hydrophobic
pockets on the surface of Nck2-SH2, and thus do not match the Grb2 phosphopeptide.
This, however, appears possible in principle, as both binding pockets are located at the
domain surface. The Nck2-loopBC (loop connecting β-strands B and C) approaches
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the Grb2-loopBG (loop connecting β-strands B and G) up to 2.5 A˚ (Cα-atoms), thus
consequently the loops would have to adopt a slightly different conformation in the
complex. LoopBC in Nck2 is rather inflexible due to being involved in a rigid β-sheet,
but loopBG of Grb2 would be able to move also indicated by slightly elevated tem-
perature factors. The overall interaction surface of the potential Grb2-SH2 –Nck2-SH2
complex would be significantly larger than a normal SH2-phosphopeptide interaction
and could involve interactions outside the canonical phosphopeptide binding site.
The existence of a Grb2 –Nck2 complex in vivo has not been indicated up to now.
However, Grb2 has been reported to colocalize with Nck proteins in quite a few cases
(see chapter 4.2.2). Recently, Grb2 and Nck2 were assigned a combined role in local-
ized actin polymerization in response to bead-bound EGF, dependent on the activation
of N-WASP (Kempiak et al., 2005). Inhibition of either Grb2 or Nck2 results in the
loss of localization of N-WASP at the activation site and reduced actin polymeriza-
tion. Suppression of Nck1, interestingly, did not induce a similar effect. A resembling
phenomenon would be expected, if a Grb2-Nck2 complex was functionally important.
4.5.3 Outlook
The detailed analysis of binding specificities of Nck1 and Nck2 SH2 domains allows
new potential interaction partners to be predicted. This should focus the investigation
of Nck binding phosphoproteins leading to the identification of its functional spectrum.
Proteins that were previously reported to bind Nck but do not bear a favorable binding
motif may need to be reinvestigated with respect to Nck binding.
GIT1, found to bear a favorable binding site for Nck, has been shown in this study to
associate with Nck in a phosphotyrosine dependent manner and is a promising can-
didate for a physiological interaction partner. Thus, as first step, the interaction of
the Nck SH2 domains with GIT1 should be substantiated by additional pull-down
and co-immunoprecipitation experiments. Beside native GIT1 and Nck SH2 domains,
also Nck-SH2 mutants (ArgβB5 to Lys) that lack the phosphotyrosine binding capa-
bility should be employed in both types of experiment. Moreover, the co-expression of
Nck with mutants of GIT1 (e.g. Tyr383 changed into Phe) and following pull-down
or co-immunoprecipitation experiments should confirm the predicted phosphotyrosine
binding site around Y383 to be responsible for the interaction. Colocalization exper-
iments e.g. with respect to focal adhesions could give first hints for the physiological
function of the GIT1 –Nck interaction. To clarify if a biochemical characterization and
subsequently structure solution of a GIT1 –Nck-SH2 complex might be possible, re-
combinant production of GIT1 or a stable domain comprising the Nck binding site
should be tested.
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The study also has shown that differences between Nck1 and Nck2 are not due to
different phosphopeptide binding specificities of their respective SH2 domains. In this
context, the analysis of a potential Grb2-SH2 –Nck2-SH2 complex may prove partic-
ularly interesting. Should phosphorylation of the necessary tyrosine in Nck2-SH2 in
vitro prove to be possible, binding experiments such as SPR or isothermal titration
calorimetry may confirm that the two SH2 domains truely interact. In parallel, a po-
tential physiological role of such a complex should be investigated through pull-down,
co-immunoprecipitation and localization experiments. Ultimately, the crystallization of
a complex of Grb2-SH2 and Nck2-SH2 could provide the first structure of an SH2 do-
main binding a true phosphoprotein instead of a phosphopeptide, potentially expanding
the present limited view of SH2 – target interactions.
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Appendix A
Interactions in crystal structures
Table A.1: Interactions in Nck1-SH2/Tir12 and Nck2-SH2/Tir8 complexes.
Tir residue Atom Nck residue Atom Type of Distance
interaction Nck1 [A˚] Nck2 [A˚]
His-2 NE2 GluBC1 OE2 hydrogen bond 3.2 3.2
Ile-1 O ArgαA2 NH1 hydrogen bond 3.0 2.9
O ArgαA2 NH2 hydrogen bond 3.0 3.0
pTyr O1P SerBC2 N hydrogen bond 3.0 3.6
OG hydrogen bond 2.7 2.6
O2P ArgβB5 NH2 hydrogen bond 2.9 3.0
ArgαA2 NE hydrogen bond 2.9 3.0
ArgαA2 NH2 hydrogen bond 2.9 2.9
O3P ArgβB5 NH2 hydrogen bond 2.8 2.7
SerβB7 OG hydrogen bond 3.1 3.6
SerβC3 OG hydrogen bond 2.8 3.0
GluBC1 N hydrogen bond 2.8 2.8
phenol ring LysβD6 hydrophobic
Asp+1 N HisβD4 O hydrogen bond 2.9 2.9
OD2 HisβD4 N hydrogen bond 2.9 2.9
Val+3 IleBF’2 hydrophobic
IleβE4 hydrophobic
TyrαB9 hydrophobic
PheβD5 hydrophobic
Ala+4 N IleBF’2 O hydrogen bond 3.0 2.9
PheβF’1 hydrophobic
Asp+6 OD1 ArgβF1 NH1 hydrogen bond 3.3 n.d.
OD2 ArgβF1 NH1 hydrogen bond 3.4 n.d.
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Appendix B
Epitope scan data
Table B.1: Averaged signals from the Nck1-SH2 epitope scans. The raw values of each
epitope scan were normalized by dividing by the average value of all positive controls from the
experiment. The binding signals of three epitope scans were averaged and the standard error
of the mean (SEM) calculated for each peptide. These data are listed below (in percentage
(%) of the average control phosphopeptide) were applied to generate figure 3.30.
E E H I pY D E V A A D P
G 78 ±9 90 ±18 25 ±8 30 ±4 0 ±0 0 ±0 0 ±0 0 ±0 17 ±3 67 ±9 30 ±4 103 ±18
A 87 ±15 104 ±20 95 ±8 59 ±6 0 ±0 3 ±2 39 ±5 7 ±2 94 ±10 121 ±7 27 ±7 102 ±8
V 81 ±6 80 ±34 79 ±10 74 ±11 0 ±0 0 ±0 47 ±4 119 ±14 17 ±4 97 ±12 14 ±5 96 ±14
L 108 ±20 81 ±12 18 ±3 90 ±10 0 ±0 0 ±0 48 ±6 0 ±0 17 ±4 91 ±6 15 ±4 113 ±17
I 76 ±8 91 ±10 51 ±3 110 ±3 0 ±0 0 ±0 64 ±5 9 ±2 7 ±2 83 ±8 16 ±3 109 ±11
M 69 ±7 72 ±8 7 ±2 68 ±18 0 ±0 0 ±0 61 ±2 0 ±0 13 ±2 94 ±11 9 ±1 125 ±10
P 89 ±7 65 ±17 90 ±15 31 ±3 0 ±0 0 ±0 54 ±1 34 ±5 56 ±5 88 ±5 23 ±5 101 ±22
F 138 ±14 77 ±6 19 ±6 94 ±5 0 ±0 0 ±0 11 ±1 0 ±0 66 ±12 58 ±9 27 ±4 88 ±22
W 76 ±10 84 ±4 57 ±8 18 ±1 0 ±0 0 ±0 1 ±0 0 ±0 3 ±1 73 ±13 12 ±2 54 ±3
Y 99 ±16 76 ±5 19 ±1 87 ±5 0 ±0 0 ±0 5 ±1 0 ±0 92 ±15 95 ±8 43 ±9 68 ±8
S 79 ±10 74 ±11 22 ±1 44 ±4 0 ±0 11 ±1 36 ±3 0 ±0 104 ±5 90 ±7 30 ±5 110 ±5
T 126 ±18 95 ±10 30 ±6 74 ±9 0 ±0 8 ±1 69 ±3 0 ±0 116 ±7 91 ±4 26 ±4 123 ±9
N 103 ±25 58 ±13 44 ±4 18 ±2 0 ±0 7 ±1 41 ±4 0 ±0 50 ±9 80 ±7 14 ±2 107 ±19
Q 70 ±12 69 ±17 29 ±2 59 ±5 0 ±0 0 ±0 82 ±3 0 ±0 55 ±3 97 ±5 21 ±4 101 ±3
C 68 ±21 60 ±12 8 ±3 35 ±2 0 ±0 37 ±14 31 ±6 0 ±0 16 ±3 78 ±11 86 ±21 104 ±9
H 94 ±22 86 ±15 90 ±9 60 ±9 0 ±0 3 ±1 22 ±1 0 ±0 24 ±2 88 ±1 19 ±2 106 ±17
K 70 ±15 65 ±5 0 ±0 42 ±10 0 ±0 0 ±0 44 ±8 0 ±0 0 ±0 81 ±10 2 ±0 74 ±15
R 82 ±18 60 ±11 21 ±2 37 ±3 0 ±0 0 ±0 33 ±2 0 ±0 2 ±0 77 ±6 0 ±0 63 ±10
D 112 ±25 94 ±11 23 ±2 63 ±7 0 ±0 107 ±3 72 ±4 0 ±0 50 ±3 114 ±11 85 ±11 67 ±22
E 95 ±13 93 ±10 18 ±2 87 ±9 0 ±0 27 ±3 92 ±16 1 ±0 63 ±2 96 ±6 111 ±4 47 ±18
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Table B.2: Averaged signals from Nck2-SH2 epitope scans. The raw values of each
epitope scan were normalized by dividing by the average value of all positive controls from the
experiment. The binding signals of three epitope scans were averaged and the standard error
of the mean (SEM) calculated for each peptide. These data are listed below (in percentage
(%) of the average control phosphopeptide) and were applied to generate figure 3.30.
E E H I pY D E V A A D P
G 56 ±8 56 ±10 10 ±8 8 ±3 0 ±0 0 ±0 0 ±0 2 ±1 3 ±3 39 ±13 23 ±7 86 ±7
A 132 ±42 96 ±17 41 ±5 27 ±14 0 ±0 0 ±0 16 ±7 1 ±0 100 ±6 115 ±17 6 ±3 124 ±17
V 93 ±12 41 ±19 60 ±12 60 ±14 0 ±0 1 ±0 44 ±11 119 ±18 1 ±1 63 ±12 5 ±4 120 ±7
L 96 ±20 63 ±20 3 ±2 103 ±26 0 ±0 0 ±0 21 ±5 0 ±0 4 ±2 82 ±18 6 ±3 126 ±15
I 84 ±7 60 ±4 29 ±7 89 ±15 0 ±0 0 ±0 44 ±5 1 ±1 1 ±1 57 ±17 9 ±4 162 ±25
M 46 ±23 46 ±18 1 ±1 64 ±20 0 ±0 1 ±1 44 ±2 1 ±1 2 ±1 68 ±18 1 ±1 164 ±4
P 83 ±1 42 ±12 66 ±17 12 ±3 0 ±0 0 ±0 28 ±9 10 ±1 14 ±4 77 ±18 8 ±5 96 ±4
F 135 ±16 89 ±6 5 ±5 64 ±2 0 ±0 1 ±0 4 ±0 1 ±1 45 ±12 52 ±16 15 ±12 133 ±29
W 82 ±21 43 ±8 30 ±6 7 ±4 0 ±0 0 ±0 1 ±0 0 ±0 2 ±1 34 ±19 4 ±2 24 ±10
Y 108 ±13 38 ±6 8 ±3 75 ±12 0 ±0 0 ±0 2 ±1 0 ±0 76 ±9 71 ±4 37 ±6 111 ±16
S 70 ±20 46 ±7 6 ±2 28 ±9 0 ±0 3 ±1 30 ±14 0 ±0 97 ±5 89 ±19 21 ±6 121 ±7
T 82 ±13 62 ±6 6 ±3 70 ±17 0 ±0 2 ±1 72 ±15 0 ±0 113 ±8 83 ±19 18 ±6 109 ±8
N 80 ±28 45 ±15 33 ±11 9 ±4 0 ±0 2 ±2 22 ±3 2 ±2 12 ±7 60 ±13 1 ±1 137 ±19
Q 81 ±11 45 ±8 12 ±4 31 ±3 0 ±0 1 ±1 62 ±10 1 ±1 15 ±3 92 ±13 7 ±3 111 ±12
C 64 ±17 53 ±10 0 ±0 18 ±3 0 ±0 19 ±3 15 ±6 3 ±3 8 ±4 80 ±5 51 ±71 133 ±12
H 78 ±29 57 ±10 125 ±22 27 ±3 0 ±0 0 ±0 5 ±2 0 ±0 8 ±4 59 ±21 8 ±4 113 ±19
K 53 ±17 40 ±17 1 ±1 27 ±12 0 ±0 1 ±1 17 ±2 1 ±0 0 ±0 57 ±13 2 ±2 50 ±31
R 73 ±40 38 ±5 7 ±4 21 ±6 0 ±0 1 ±1 21 ±7 0 ±0 0 ±0 57 ±6 0 ±0 42 ±10
D 116 ±47 87 ±33 5 ±1 22 ±3 0 ±0 97 ±19 39 ±13 0 ±0 35 ±3 159 ±29 98 ±8 121 ±15
E 122 ±33 106 ±18 3 ±2 44 ±3 0 ±0 8 ±4 62 ±16 0 ±0 44 ±18 121 ±17 86 ±10 147 ±63
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